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Abstract 
 
Proteins participate in nearly every function of living cells, and an estimated 50% are associated 
with a metal ion or cofactor. Most, if not all, of the fundamental chemical processes necessary for life, 
including photosynthesis and respiration, are facilitated by one or more metalloenzymes or 
metalloproteins. Metal-nucleic acid interactions are also clinically important in cancer and infection 
treatment, and are useful in industrial purposes. The relationship between macromolecule and metal 
can almost be viewed as symbiotic – metals often function at extreme limits when free in solution, 
with minimal ligands; on the other had, amino and nucleic acid polymers have limited functional 
capabilities. By capturing and precisely holding metal ions, biomolecules tame their reactivities by 
tuning their electronic and geometric – and therefore functional – properties, allowing the metal and 
protein together to perform precise chemical functions. However, despite decades of research, the 
intricate details of how this precision is imparted, in each case and more generally, are not entirely 
understood. In particular, the roles of long-range (beyond 1-2 bonds), non-covalent interactions are 
understood to be important; however, exactly how they impart function, is difficult to disentangle, 
due to the delicate balance resulting from evolution. Moreover, many of these systems, such as the 
oxidases and photosystems responsible for respiration and photosynthesis, respectively, are large, 
difficult to purify, and contain multiple cofactors that complicate investigations of the active site 
chemistry. 
Therefore, in the Lu lab, we have been pioneers of the “biosynthetic” modeling approach, in which 
the active sites of complex enzymes are structurally reconstructed in small, experimentally tractable 
proteins. In this vein, the active site of heme-copper oxidases (HCOs) – a bimetallic heme-copper 
center known as CuB – was previously structurally modeled in sperm whale myoglobin, by 
introducing two additional histidine residues, giving a protein called CuBMb. Further structural 
modeling of this protein to include additional structural features, such as a tyrosine residue, brought 
about not only partial HCO-like oxygen reduction activity, but an unexpected observation – the Cu 
ion was found to not be necessary for imparting this function, nor did it seem to improve it, in the 
designed protein. On the other hand the presence and positioning of the tyrosine had a dramatic 
effect on this activity. 
This thesis describes efforts to first understand the reaction of these CuBMbs with oxygen. It is 
found that the extended hydrogen bonding network, stabilized by the introduced residues and 
consisting of water molecules, is critical for imparting oxygen reduction activity to an oxygen binding 
protein. Based on this observation, further designs are pursued to improve this hydrogen-bonding 
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network, in an effort to improve activity. It is found that incorporation of a glutamate within 
hydrogen bonding distance of one of the water molecules composing the extended hydrogen bonding 
network improves the function of the enzyme by eliminating the ROS release. Moreover, 
spectroscopic and crystallographic evidence support that this improvement is due to enhanced 
hydrogen bonding and protonation to the oxygen intermediate. This design demonstrates the critical 
importance of long-range interactions in enzymes, and should inspire enzyme engineers to pursue 
incorporation of these types of features. 
In addition to these studies, this thesis also reports the computational design of a novel 
heterobimetallic heme-Fe4S4 site, and progress in obtaining the first crystal structure of a metal 
mediated catalytic DNA construct. 
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CHAPTER 1  
INTRODUCTION† 
1.1. Bioinorganic chemistry 
It is taken as well established common knowledge that nucleic acid molecules and protein 
machines define and produce cellular function and life. On the other hand, the role that metals 
play in enabling the functions of life often seem glossed over in common understanding. This is 
despite the fact that more than half of proteins present in living organisms contain metal and most 
of the complex fundamental processes of life are driven by metal-based chemistry.1 Given this 
observation, it is not surprising that the study of metal-mediated chemistry in biology is an 
established discipline known as bioinorganic chemistry. 
The understanding of how metal ions are incorporated in and utilized by natural as well as 
non-natural proteins and nucleic acids is a major area of bioinorganic chemistry. Interactions of 
natural and artificial RNA and DNA sequences with metal ions that inhibit their function or impart 
new function has enabled discoveries that treat cancers,2 prevent and treat viral infections,3 and 
allow metal ion sensing.4 Similarly, in natural proteins, the functions of metals include structural 
support and sensing,5,6 electron transport and transfer,7,8 and direct interaction with and 
modification of substrates,9-11 among others. Given the utility of proteins in mediating metal 
function, the design of artificial metalloproteins and metallopeptides has seen substantial activity 
and success.8,12-25 
1.2. Oxygen activation by terminal oxidases – structure and activity 
One of the fundamental chemistries of life on earth is the activation of oxygen for reduction 
in a controlled manner. This is important because oxygen, while highly abundant and a strong 
oxidant – making it an attractive electron sink for extracting energy from foods and fuels – is 
kinetically inert.26 This property of oxygen is generally a good thing and is what allowed oxygen to 
build up in the atmosphere without the spontaneous combustion of all organic molecules.26 
Chemically, clean oxygen activation is often achieved by allowing oxygen to bind to a metal atom 
or ion, altering its electronic properties.26 A prominent example of oxygen activation in biology is 
in aerobic respiration, where the oxidizing chemical potential of oxygen is utilized to drive synthesis 
of adenosine triphosphate (ATP), the ubiquitous energy source for biological processes. The 
                                                          
† Portions of this chapter have been taken from the following manuscript: 
Petrik, I. D., Davydov, R., Ross, M., Zhao, X., Hoffman, B., Lu, Y.; “Spectroscopic and crystallographic evidence for the role of a water-
containing hydrogen bonding network in oxidase activity of an engineered myoglobin” J. Am. Chem. Soc. (accepted) doi: 
10.1021/jacs.5b12004 
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extraction of this energy from oxygen is efficiently catalyzed by large membrane-spanning enzymes 
called terminal oxidases, which activate oxygen for complete reduction and use the energy to 
generate a proton gradient across a lipid bilayer membrane.27-29 Re-equilibration of this proton 
gradient operates the ATP synthase enzyme, which produces ATP in the cell. 
 
Figure 1.1. Molecular structure of cytochrome c oxidase (CcO) from bovine heart at 2.8 Å resolution (1OCC).30 
The majority of terminal oxidases comprise a family of enzymes known as heme-copper 
oxidases (HCOs), so named because they contain heme cofactors and copper ions.27,28  The 
molecular structure of one member of this family, known as cytochrome c oxidase (CcO), is shown 
in Figure 1.1.30 The structure of the active site of CcO at which oxygen binds is shown in Figure 1.2. 
This site lies in the core of CcO and consists of two adjacent metal ions: an iron ion contained in a 
heme cofactor, and a copper ion ligated by three His residues, named CuB. One of these His 
sidechains also forms a covalent link to a nearby Tyr – a feature unique to HCOs.9,28,31 Altogether, 
this active site is known as the CuB site. A small fraction of organisms use an alternative terminal 
oxidase enzyme, known as cytochrome-bd oxygen reductase, due to its use of two different types of 
heme, heme-b and heme-d (Figure 1.3).29 No atomic resolution structure of this enzyme has been 
published, however it is believed that oxygen binding and reduction occurs at a b-,d- diheme site.32 
The general mechanism of oxygen reduction at a heme center is shown in Figure 1.4. It can 
be seen from this mechanism that complete cleavage of the O-O bond after oxygen binding requires 
efficient delivery of one additional electron and two additional protons to the heme-oxygen moiety. 
Subsequent recovery of the oxygen-binding state requires delivery of three additional electrons and 
3 
 
two additional protons. Given the size of terminal oxidases (~105 Da) and their location within the 
hydrophobic membrane, the availability of these basic components at the active site is not a trivial 
concern. Delivery of electrons in HCOs, as in many large metalloenzymes, is enabled by the use of 
a series of metal ion cofactors, along which electrons hop to reach the active site (Figure 1.5).27,28 In 
order to enable efficient proton delivery, terminal oxidases have evolved water-mediated hydrogen 
bonding networks called proton channels.27,28 
 
Figure 1.2. Structure of the oxygen binding site of CcO (1OCC).30 The iron is shown as an orange sphere and 
copper is shown as a teal sphere. Rendered in VMD. 
To elucidate structural features responsible for efficient oxygen activation in these and 
related enzymes, biochemical and biophysical studies of the enzymes have identified potential 
amino acid residues that may play key roles in the reaction,33-42 and their importance has been 
confirmed by loss of activity in site-directed mutagenesis (SDM) studies.34-39,43-45 However, these 
mutations often cause structural perturbations in addition to those directly being investigated, 
which may explain the loss of the function. For instance, it is known that removal of CuB from the 
active site by mutagenesis or chemical methods eliminates oxidase activity,35,36,43-46 whether the role 
of the Cu is to cleave the O-O bond or simply to donate electrons upon oxygen binding remains 
unclear.39,40,44,47-52 Moreover, the SDM studies reveal only necessary, but not necessarily minimally 
sufficient structural features for function. In addition, direct studies of these enzymes are 
complicated by their large size (~105 Da), membrane spanning localization, and presence of 
additional metal sites and cofactors which interfere with spectroscopic studies of their active sites. 
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Figure 1.3. Structures of hemes discussed in this thesis. 
 
Figure 1.4. General mechanism of oxygen reduction in heme proteins. 
To overcome these limitation, structural and functional synthetic models of native enzymes 
have been prepared and their studies have offered deeper insights into the structural features 
responsible for oxidase activity.54-65 These model systems typically consist of Fe-porphyrin 
molecules with either covalently linked His analogue moieties,56,60,62,63 or independent tridentate 
pyridine complexes that bind Cu and form an oxygen mediated complex with the Fe-porphyrin 
upon oxygen addition.61,64,65. In these systems, a hydrophobic environment is provided by organic 
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solvent. Several examples of models incorporating an analogue of the His-Tyr crosslink have been 
reported,62,66-69 however models incorporating un-crosslinked His and Tyr analogues have not. 
 
 
Figure 1.5. Schematic representation of proton and electron delivery into the active site of R. sphaeroides.53 
Despite these successes, small molecule mimics have important limitations. These 
molecules are incompatible with physiological aqueous conditions, despite the fact that water is a 
key component of HCOs and their activity. In addition, building long, well-defined hydrogen 
bonding networks, that might mimic the proton channels in HCOs, is a substantial synthetic 
challenge. Therefore, while studies of the native enzymes and their model systems have yielded 
numerous insights,9,27-29,33,34,60,61,70-72 an understanding of general features responsible for oxygen 
activation is still being sought. 
1.3. “Biosynthetic” modeling approach 
As a complementary approach to the studies of native enzymes and their synthetic models, 
that overcomes their limitations, use of small designed metalloproteins and metallopeptides has 
shown remarkable success.25,73-78 In particular, the Lu lab employs a “biosynthetic modeling” 
approach, based on a small, natural protein scaffold, to gain a fundamental understanding of 
sufficient features conferring oxidase activity, i.e., 4e- reduction of O2 to H2O.13,73,79-85 In contrast to 
native proteins, such as HCOs, which are membrane proteins that are not easy to prepare to 
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homogeneity with high yields, and contain accessory metal-binding sites that complicate 
investigations, biosynthetic models are much simpler to synthesize and contain metal cofactors 
only in the desired site. Thanks to recent advances in biology, biosynthetic models of complex 
metal-binding sites such as in HCOs can be prepared more easily and with higher yields than using 
organic molecule ligands. Furthermore, the biosynthetic approach, using a small, stable, and well-
characterized protein, such as sperm whale myoglobin (Mb), as the scaffold makes the model 
amenable to study under physiologically relevant conditions. Moreover, the structurally rigid 
scaffold protein allows defining long-range non-covalent interactions and probing their roles more 
precisely. 
Several uses of Mb as a scaffold for studying alternative activities were reported previously. 
Watanabe and coworkers enhanced the peroxidase activity of Mb by replacing His64 with Leu and 
introducing a His at position 29 (L29H) or 43 (F43H), based on structural similarity to cytochrome 
c peroxidase (CcP).86-89 His64 was removed to increase the lifetime of the highly reactive ferryl-
porphyrin radical state (por+•-Fe(IV)=O; Cpd(I)).86-88 The F43H-H64L-Mb did produce enhanced 
peroxidase activity.86,89 Similarly, Watanabe and coworkers gradually rationally engineered Mb to 
carry out peroxygenase chemistry,88,90-94 similar to the peroxide shunted mechanism of 
cytochromes P450.95 The final variant, H64D-V68I-F43W-Mb carried out quantitative 
peroxygneation of the introduced Trp43 to 2,6-dihydro-2,6-dioxoindole.94 
1.4. Design of HCO models in myoglobin 
1.4.1. Design and characterization of CuBMb 
Using the biosynthetic modeling approach, Sigman et al. previously reported the design of 
a structural HCO mimic in sperm whale myoglobin (Mb).96 Several favorable properties of Mb drove 
this as the chosen of scaffold for this project: (1) it is a small (17.4 kDa), soluble protein that can be 
easily produced in high-yield by recombinant expression in E. coli; (2) it possesses a heme and is 
known to bind oxygen – indeed it’s native function is oxygen storage;97 (3) it is stable and known to 
be amenable to mutagenesis;86,89,92,94,98-100 (4) it is relatively easy to crystallize and was in fact among 
the first protein whose crystallographic structure was solved,101 facilitating structural 
characterization (Figure 1.6); (5) it is spectroscopically well characterized, facilitating interpretation 
of spectroscopic studies.97,102-106  
The design of a structural mimic of the CuB active site of HCOs in Mb initially focused on 
introducing the Cu binding site in the heme pocket of Mb. This was carried out by computational 
overlay of the heme groups of both proteins and visual inspection to determine which residues to 
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consider mutating to His, that would allow formation of a tridentate-His Cu binding site,96 further 
confirmed by molecular modeling. The introduced residues – L29H-F43H – in combination with 
the native His64, were predicted to bind a Cu ion within 5.4 Å of the heme-Fe,96. This protein, called 
CuBMb, was shown to bind Cu(II) upon titration, with a modest Kd ~9 μM.96 It should be noted that 
the purification of CuBMb and its variants without Cu in the CuB site allows the metal to be easily 
substituted, a feat that is impractical or impossible to accomplish in native HCOs. 
 
Figure 1.6. Structures of wtMb. (A) Overall structure of wtMb with helices labeled. (B) and (C) Structures of 
the active site of wtMb in the resting Fe(III) (B) and oxygen bound Fe(II)-O2 (C) forms, showing all residues 
within 7 Å of the distal oxygen atom.102 
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Subsequently, CuBMb was shown to catalyze heme-oxygenase(HO)-like chemistry in the 
presence of Cu(II) and reductant at pH 8.0.107 HO-like heme degredation proceeds by reduction of 
heme-bound oxygen to peroxide, followed by subsequent attack of the heme by the peroxide 
ligand.10,108-111 Chemical reduction of oxy-heme to peroxo-heme is a catalytic step that HO shares in 
common with terminal oxidases, but not myoglobin, and suggested that Cu may indeed play a role 
in activating heme-bound oxygen for reduction to peroxide. Given that HO and HCO mechanisms 
deviate in that the peroxo intermediate of HCOs is rapidly protonated, while in HOs it is not and 
attacks the heme, it was hypothesized that inadequate protonation during turnover of Cu(II)-
CuBMb may explain its inability to perform oxygen reductase chemistry.10 Therefore, incorporating 
other structural features that may facilitate protonation became a priority. 
1.4.2. Achieving NO reduction in myoglobin – FeBMb 
In addition to catalyzing oxygen reduction, a subclass of enzymes in the HCO family 
specialize in reduction of nitric oxide to nitrous oxide.112-114 These nitric oxide reductases (NORs) 
share many similar structural features with the oxygen reductases,112,115-117 including a heme-non-
heme metal site at which NO reduction occurs.112-114 Several key structural differences distinguish 
nitric oxide reductases from oxygen reductases: (1) the active site – called the FeB site – consists of 
heme, as in HCOs, however the non-heme metal site contains Fe rather than Cu; (2) in addition to 
the three His residues used by HCOs to bind Cu, the non-heme iron is also ligated by a Glu residue; 
(3) NORs lack the His-Tyr crosslink group and possess a second glutamate in their secondary 
coordination sphere.112,118 Based on a structural overlay of a sequence homology model of an NOR, 
whose structure was unknown, CuBMb was modified to contain a Glu residue – V68E – that could 
ligate the non-heme metal.119 This protein, called FeBMb, was shown to bind Fe in the non-heme 
site and displayed the activity of native NORs.119 Impressively, once the structure of native NOR 
from P. aeruginosa was solved,112 it was shown that FeBMb shared substantial structural similarity 
to native FeB sites. The success of this design was a galvanizing force in metalloenzyme engineering, 
showing that the chemistry of large transmembrane proteins with multiple cofactors can be 
reproduced in smaller, more experimentally tractable scaffold proteins. 
This system has been used as the foundation for elucidating the fundamental chemistry of 
NO reduction at a heme-non-heme iron site.81,84,120,121 Additionally, its success inspired the extension 
of the model to include more distant structural features, such as the second, non-ligand Glu 
residue.122 This was achieved through the I107E mutation in FeBMb, which positioned the 
carboxylate sidechain near, but not ligating, the non-heme Fe (Figure 1.7).122 The importance of this 
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feature was confirmed by the observation of a ~100% increase in NO reduction activity of this 
mutant compared with the original FeBMb.122 The success of this new design clearly demonstrates 
the viability of rational secondary coordination sphere design in improving the activity of designed 
metalloenzymes, and was a significant motivator for pursuing a similar strategy to improve CuBMb. 
 
Figure 1.7. Structure of active site of I107E FeBMb with (B) and without (A) Fe bound in the non-heme site. 
1.4.3. Attempts at improving oxygen reductase activity in CuBMb 
In order to improve protonation in CuBMb during reduction of oxygen and enable complete 
O-O bond cleavage, incorporation of two related structural features into CuB was previously 
pursued: (1) the incorporation of a hydroxyl group on the heme periphery, mimicking the 
hydroxyfarnesyl moiety present on o- and a-type hemes; (2) incorporation of a tyrosine residue into 
the active site. Computational calculations of native HCOs suggest that both of these groups are 
directly involved the hydrogen bonding network that protonates catalytic intermediates.123-126 While 
the hydroxyfarnesyl group is too large to fit into Mb, synthetic heme derivatives incorporating a 
hydroxyethyl group are readily available. Moreover, replacement of the heme in myoglobin is well 
established,127 allowing the role of the heme structure in oxygen reductase activity to be uncoupled 
from changes in the overall protein. Wang et al. reported the replacement of the natural heme-b in 
CuBMb with the synthetic Fe-2(4)-hydroxyethyl-4(2)-vinyldeutroporphyrin (Fe-HVD; heme-o 
mimic).128 Assays of this protein showed 19-fold lower heme-degradation rate under Cu-dependent 
reduction conditions, which was interpreted to suggest that the hydrogen bonding network of the 
active site was altered and regulated the activity of CuBMb.128 
Independently, Miner et al. investigated the role of the tyrosine in oxygen reductase activity 
by CuBMb. In native HCOs, this tyrosine can exist on either the same helix as the histidine it is 
crosslinked with, or on an adjacent helix.9,28,31,129 Two Tyr containing CuBMb variants were designed 
and engineered based on structural overlay with two different known HCO structures (Figure 1.8): 
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F33Y-CuBMb was engineered based on structure and sequence comparison with bovine CcO, 
placing Tyr 4 residues downstream from His29; G65Y-CuBMb was designed and engineered based 
on structural overlay with cbb3 cytochrom oxidase from P. stutzeri. Oxygen consumption of these 
proteins under reductive conditions was measured directly using an oxygen electrode. Additionally, 
based on the hypothesis that proton delivery during turnover needed to be improved, assays were 
carried out at pH 6.0 rather than 8.0. Under these conditions, it was observed that the tyrosine 
residues did improve the oxygen reductase activity of CuBMb substantially (Figure 1.9A), with a 
majority – though notably not all – of the oxygen reduced completely to water. The production of 
water was confirmed by NMR experiments in which production of H217O from 17O2 by the proteins 
was observed under reductive conditions (Figure 1.9B). Moreover, F33Y CuBMb and G65Y CuBMb 
were able to achieve over 500 and 1000 turnovers of oxygen reduction, respectively. It is important 
to note that the oxygen reductase chemistry of these CuBMb proteins was independent of presence 
and identity of metal ion (see Section 1.5 for further discussion).  
 
Figure 1.8. Structural overlays of F33Y-CuBMb (crystal structure) and G65Y-CuBMb (molecular model), with 
their inspirational native HCO structures. 
The role of tyrosine was further investigated by Yu, et al., by incorporating a series of 
unnatural tyrosine analogues with varying reduction potentials and pKas into position 33.130 It was 
found that the rate of activity as well as the fraction of water production increased as pKa decreased, 
suggesting a role for proton transfer and the role of tyrosine in defining the oxygen reductase 
activity of CuBMb. Similarly, the role of the electronic properties of the heme were investigated by 
Bhagi-Damodaran et al., by incorporating a series of unnatural heme cofactors with varying electron 
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withdrawing substituents.13 It was found that the apparent rate of O2 reduction increased as the 
reduction potential increased, approaching the potential of a-type HCOs. 
 
A 
 
B 
 
Figure 1.9. (A) Oxygen consumption rates of indicated proteins leading to formation of water or ROS, as 
indicated. (B) NMR detection of H217O produced by reaction of proteins with 17O2 under reductive conditions. 
1.5. Thesis overview 
The previous results showed myoglobin could be successfully imparted with oxygen 
reductase function by incorporation of three mutations in the distal site pocket; however, this 
activity is not entirely complete, as some of the oxygen consumed is released as reactive oxygen 
species (ROS). Moreover, the structural and electronic features that impart this activity in the 
absence of metal ion are still being investigated. Chapter 2 describes further characterization of this 
generation of CuBMb proteins, with particular focus on the electronic and structural properties of 
oxygen bound to the heme. Crystal structures are reported of the G65Y-CuBMb, Cu(II)-F33Y-
CuBMb, and oxy-F33Y-CuBMb. Chapter 3 describes progress in improving the oxygen reductase 
activity of CuBMb, based on the conclusions and hypotheses drawn from the results of Chapter 2. 
First, attempts to improve oxygen reductase activity by introducing a proton channel into F33Y-
CuBMb are reported. Finally, improvement of CuBMbs to abolish release of ROS by incorporation 
of the I107E mutation is reported, and the design hypothesis of this mutation is confirmed using 
EPR spectroscopy and crystallography of oxy-I107E-CuBMbs. 
The final two chapters contain substantial work that is not related to the understanding or 
engineering of HCOs, NORs, or their models, but is more generally involved in the design and 
structural understanding of artificial bioinorganic catalysts. Chapter 4 describes the rational 
computational design of a unique heme-[Fe4S4] cofactor into CcP, which is expected to facilitate 
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multielectron reduction of substrates such as sulfite and nitrite. Chapter 5 describes recent progress 
in obtaining the crystal structure of an active metalloDNAzyme in its active form. Only one atomic 
resolution structure of an active DNAzyme is known, and such information about 
metalloDNAzymes would be invaluable in guiding rational design of these versatile artificial 
catalysts. 
Additionally, the thesis contains several appendices which describe improved methods, 
apparatuses, programs, and protein constructs, as well as a few additional, unrelated crystal 
structures. 
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CHAPTER 2  
CHARACTERIZATION OF TYROSINE CONTAINING MUTANTS OF CuBMb‡ 
2.1. Introduction and motivation 
While the observed oxygen reducing activity of the designed tyrosine-containing CuBMb 
proteins reported by Miner et al. is remarkable, it also raised interesting questions. First – why did 
the presence of Cu(II) or any other metal in the CuB site of these proteins not significantly affect 
their oxygen reductase activity? In native HCOs, which Cu(II)-CuBMb is a structural model of, 
oxygen reductase activity is seen to be abolished when the Cu in the CuB site is removed, chemically 
or by mutagenesis.35,36,43-46 However, the CuB site in HCOs is the result of very extensive evolution, 
and whether it is necessary for oxygen reduction to water in general, or has simply evolved to take 
on several necessary roles within the context of HCOs is unclear.1-9 Rapid delivery of electrons to 
oxygen upon binding in the CuB site is important for efficient oxygen reduction, and it is 
hypothesized that the role of CuB may simply be to allow storage of the necessary electron near the 
heme.4,6 Indeed, it is shown that electronic coupling between the heme and CuB allows CuB to be 
reduced before the heme iron and therefore prevents oxygen from binding before CuB is reduced.1 
Cytochrome-bd oxygen reductases catalyze the same chemistry and are not known to possess a CuB 
site, although the two hemes in this protein are proposed to be in close proximity, with one Fe 
potentially serving the role of CuB.10-13 Similarly, cytochromes P450, which reduce oxygen and 
promote heterolytic O-O bond cleavage similar to HCOs do not have an additional metal in the 
active site;14 however, in these enzymes, the heme is ligated to the protein by a Cys residue rather 
than His used in HCOs and CuBMb, so they are not directly comparable. 
A related question is – if presence of Cu in the CuB site of CuBMb is not necessary for oxygen 
reduction to water, what are the structural features of this site in CuBMb that are responsible for 
imparting oxidase activity? The known reactivity of wtMb with oxygen is binding and release of 
oxygen, or autooxidation of oxy-Mb releasing superoxide.15 It is also known that reaction of 
hydrogen peroxide with Mb leads to O-O bond cleavage.16,17 Therefore, it is hypothesized that the 
F33Y-CuBMb and G65Y-CuBMb promote reduction of the oxy-ferrous state to the peroxo-ferric 
                                                          
‡ Portions of this chapter have been taken from the following manuscripts: 
Miner, K. D., Mukherjee, A., Gao, Y.-G., Null, E. L., Petrik, I. D., Zhao, X., Yeung, N., Robinson, H., Lu, Y; "A Designed Functional 
Metalloenzyme that Reduces O2 to H2O with Over One Thousand Turnovers" Angew. Chem. Intl. Ed. 51, 5589-5592 (2012) 
Petrik, I. D., Davydov, R., Ross, M., Zhao, X., Hoffman, B., Lu, Y.; “Spectroscopic and crystallographic evidence for the role of a water-
containing hydrogen bonding network in oxidase activity of an engineered myoglobin” J. Am. Chem. Soc. (accepted) doi: 
10.1021/jacs.5b12004 
Petrik, I. D., Davydov, R., Kahle, M., Sandoval, B., Ädelroth, P., Hoffman, B., Lu, Y.; “Enhanced oxygen activation and O-O bond 
cleavage in Ile107Glu mutants of oxygen reductase enzymes engineered from sperm whale myoglobin” J. Am. Chem. Soc. (in 
preparation) 
26 
 
state, in which the O-O bond can be subsequently cleaved by known myoglobin reaction pathways 
(Figure 2.1); however, the detailed structural features and interactions that promote this reaction 
are still unclear. 
 
Figure 2.1. Proposed mechanisms of oxygen reduction by F33Y CuBMb in solution compared with wtMb. 
Herein, I first briefly describe some interactions of Cu(II) with F33Y-CuBMb and G65Y-
CuBMb, including affinities and attempts to achieve electronic coupling between the heme-Fe and 
CuB. Subsequently, I describe studies of the Cu-free form of the protein attempting to gain insight 
into how the structural features of CuBMb interact with bound oxygen and impart oxygen reductase 
activity. 
2.2. Metal binding properties 
The Cu(II) binding titration curves and Kd values for F33Y-CuBMb and G65Y-CuBMb are 
given in Figure 2.2. The ability of Cu(II) to bind in the CuB site of F33Y-CuBMb was further confirmed 
by crystallography (Figure 2.3). These affinities, in the μM range, are modest; however, at least for 
F33Y-CuBMb (Kd = 1.8 μM), it is below the concentration used for activity assays. Therefore, it is 
surprising that Cu(II) has minimal effect on the oxygen reductase activity of F33Y-CuBMb.  
It was hypothesized that reduction of heme and binding of oxygen before Cu(II) is reduced 
may prevent Cu from improving oxygen reductase activity. In HCOs, Cu reduction before oxygen 
binding is ensured by electronic coupling between the Fe and Cu.18-20 To determine whether such 
coupling could be observed in F33Y-CuBMb or G65Y-CuBMb under any conditions, EPR 
spectroscopy was pursued. Based on the observation of Glu mediated coupling in Fe(III)-FeBMb, 
acetate was also used to increase the likelihood of coupling. The EPR spectra of F33Y-CuBMb and 
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G65Y-CuBMb are shown in Figure 2.4. In phosphate buffer, addition of Cu(II) to both proteins did 
result in heme signal decrease as observed by EPR. However, this decrease was also observed with 
wtMb (Figure 2.4), and could be attributed to protein precipitation in the presence of Cu(II) and 
phosphate at these concentrations. To avoid this, the EPR Cu(II) titrations were again carried out 
in Bit-Tris buffer (Figure 2.5). Under these conditions, no substantial decrease of heme signal was 
observed for CuBMb or F33Y-CuBMb. While a decrease of the heme signal was observed in G65Y-
CuBMb, given the minimal coupling even at mM concentrations used in EPR experiments, it is 
unlikely to play a rrole under turnover conditions at 18 μM concentrations. Based on these results, 
it seems possible that Cu(II) bound to these proteins may remain Cu(II) throughout their catalytic 
cycle, because it cannot be reduced before the heme and before oxygen binds. Investigations of 
oxygen reduction with a variety of metals in FeBMb are currently being actively pursued and 
producing exciting results. 
 
Figure 2.2. Cu(II) titration curves of F33Y-CuBMb and G65Y-CuBMb, including affinity. 
 
Figure 2.3. Crystal structure of Cu(II)-F33Y-CuBMb (4FWY; stereo). The blue mesh is the anomalous signal 
from data collected at above the Cu K-edge, while brown mesh is anomalous signal from data collected at 
below the Cu K-edge energy. 
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Figure 2.4. EPR spectra and normalized heme signal intensities of wtMb (A), F33Y-CuBMb (B), and G65Y-
CuBMb(C), with Cu(II), and with and without acetate, in phosphate buffer. 
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Figure 2.5. EPR signals of CuBMb (A), F33Y-CuBMb (B), and G65Y-CuBMb (C) with Cu(II), and with and 
without acetate, in Bis-Tris buffer. No decrease in heme signal was observed in CuBMb or F33Y-CuBMb. A ~2-
fold decrease of the high-spin heme signal was observed in G65Y-CuBMb upon addition of 5 eq of Cu(II); 
however, given the minimal coupling even at mM concentrations of Cu(II), it is not expected to play a 
substantial role during turnover carried out at 18 μM. 
2.3. The extended hydrogen bonding network in oxy-CuBMb proteins 
The observation of oxygen reduction completely to water in CuBMb proteins even in the 
absence of Cu raised the question of how exactly 3 active site mutations converted Mb, an oxygen 
storage protein, into oxygen reducing enzymes capable of >500 turnovers. Crystal structures of 
CuBMb and F33Y-CuBMb obtained previously (Figure 2.6) reveal that the His and Tyr mutations 
introduced an intricate hydrogen bonding network, including additional water molecules in the 
active site. 
Recently, several crystal structures of G65Y-CuBMb in its resting state have been obtained. 
Interestingly, two low resolution crystal structures revealed two distinct configurations of the active 
site (Figure 2.7). In one, the sidechain of Tyr65 points into the active site and engages in a hydrogen 
bond with the waters in the active site. In this configuration, His29 is displaced from the active site. 
30 
 
In the alternative configuration, His29 is involved in hydrogen bonding in the active site, as seen in 
CuBMb, and Tyr33 is displaced. In addition, a high resolution structure (Figure 2.6C,D) of G65Y-
CuBMb was obtained similarly revealing two overlapping structural configurations of the active site. 
In addition to the features observed in the first two structures, an additional water is observed here, 
which likely only exists in the conformation in which Tyr is in the active site. Also, in this 
configuration, while the His29 is displaced from the active site, it maintains a hydrogen bond with 
Tyr65, suggesting that it may still be involved in the extended hydrogen bonding network of G65Y-
CuBMb. 
 
Figure 2.6. Crystal structures of CuBMb (A), F33Y-CuBMb (B), and G65Y-CuBMb (C, D). 
Computational calculations of HCOs have suggested that a hydrogen bonding network 
within the active site, linking the tyrosine with the bound oxygen, is necessary for oxygen 
reduction.21-24 Similarly, in cytochrome P45o monooxygenases, which also catalyze reductive O-O 
bond cleavage of oxygen, a hydrogen bonding network involving water molecules and protic 
residues is known to be engaged in interactions with the bound dioxygen and necessary for oxygen 
activation.14,25-29 Therefore, the observation of such extensive hydrogen bonding networks mediated 
by water molecules in our CuBMb proteins raised the question of what role, if any, they play in 
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activating oxygen and converting an oxygen storage protein into a an oxygen reductase. In order to 
investigate this question, I endeavored to probe the electronic properties of oxygen bound to these 
proteins. 
 
Figure 2.7. Low resolution crystal structures of G65Y-CuBMb showing the two distinct conformations of the 
active site. 
2.3.1. Characterization by EPR of cryoreduced oxy-CuBMbs 
EPR has been widely used to probe the environment of O2 activating iron enzymes.25,30-45 
Although oxy-heme is an electronically closed shell system not exhibiting any signal in EPR spectra, 
EPR spectroscopy has been used to offer insight into the properties of oxy-heme, such as its 
interactions with residues around it and its intermediates upon reduction, by a method called 
cryoreduction.46 Briefly, the oxy-heme protein, trapped at 77K, is exposed to gamma radiation, 
releasing “free” electrons into the sample matrix, which efficiently reduce EPR-silent oxy-heme into 
EPR-active peroxo-heme. Because cryogenic trapping suppresses thermal relaxation and 
equilibration of the protein and its active site, EPR spectra of the resulting sample, maintained at 
77K, provide valuable structural information on the oxy-heme precursor (Figure 2.8).30,35-42,46 
Furthermore, as the radiolytically generated peroxo-heme products are intermediates along the 
pathway of oxygen reduction, EPR spectra of the species that arise in their subsequent decay 
provide further mechanistic insight into the reaction (Figure 2.1).30,46-51 This decay is achieved by 
stepwise warming of the samples at increasing temperatures, followed by rapid re-cooling to 77K 
after each step to trap intermediates – a procedure called annealing. As a result, EPR spectroscopy 
32 
 
in combination with cryoreduction and annealing has been successfully used over the last two 
decades to probe the structure and interactions of dioxygen in many heme proteins, including 
myoglobins and monooxygenases.25,30,35-51 Because wtMb, the scaffold for F33Y-CuBMb, was among 
the first and most studied proteins by the above method, the abundance of results facilitates 
understanding of the latter by direct comparison. 
 
Figure 2.8. Formation and trapping of (hydro)peroxo products reflective of oxy protein states by 
cryoreduction.  
2.3.1.1. EPR and ENDOR characterization of cryoreduced oxy-F33Y CuBMb 
Figure 2.9 shows the EPR spectra of oxy-wtMb and oxy-F33Y-CuBMb cryoreduced at 77K, 
obtained under the same conditions. The wtMb spectrum shows the signal from a single species 
with g = [2.22, 2.13, 1.96] (see Figure 2.10 for spectra at other temperatures) whose EPR parameters 
(Table 2.1) identify it as a ferric-peroxo state, in which the peroxo ligand is H-bonded to the distal 
His-64.35-38,46 In contrast, the cryoreduced oxy-F33Y-CuBMb exhibits two rhombic EPR signals 
(Figures 2.9, 2.10, and 2.11). The first, with g = [2.24, 2.13, 1.95], is similar to that of the ferric–peroxo 
species in wtMb. The second, more rhombic EPR spectrum, has g-values g = [2.29, 2.17, 1.96] that 
are in the range characteristic of ferric-hydroperoxo intermediates.25,30,37,40,41 This assignment is 
supported by 1H ENDOR measurements presented in Figure 2.12, in which the gmax = 2.24 species 
has been removed by annealing, which show a maximum proton coupling of ~9.5 MHz. Ferric-
peroxo intermediates show strongly coupled exchangeable proton signals with Amas ~14-18 
MHz,30,38,43 while hydroperoxo- exhibit a smaller coupling, Amax ≤ 13 MHz.39,40,45 The absence of 
signal with Amax > 13 MHz confirms that the more rhombic species observed in F33Y CuBMb is 
hydroperoxo-, not peroxo-. 
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Figure 2.9. EPR spectra of oxy-wtMb and oxy-F33Y-CuBMb after radiolytic reduction with a ~3Mrad dose of 
γ radiation from 60Co, and after subsequent stepwise annealing for one minute at indicated temperatures 
(sharp signal marked by asterisk is due to radiolytically generated hydrogen atoms at 77K in quartz EPR tube).  
Table 2.1. Signal parameters for EPR signals observed in cryoreduced oxy-wtMb and F33Y-CuBMb. 
 
Protein g1 g2 g3 
wtMb    
 peroxo  2.22 2.12 1.965 
 hydroperoxo2  2.32 2.18 1.943 
F33Y-CuBMb    
 peroxo  2.24 2.13 1.964 
 hydroperoxo1  2.29 2.16 1.950 
 hydroperoxo2  2.34 2.19 1.937 
1 Primary hydroperoxo product formed at 77K. 2 Hydroperoxo product formed upon annealing. 
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Figure 2.10. Full collection of EPR spectra of oxy-wtMb and oxy-F33Y-CuBMb after cryoreduction and 
annealing at various temperatures. 
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Figure 2.11. Time and temperature dependent annealing EPR studies of cryoreduced oxy-F33Y-CuBMb. 
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Figure 2.12. 1H ENDOR of oxy-F33Y-CuBMb.  2D frequency/field pattern of 35GHz 1H CW ENDOR spectra of 
the cryoreduced oxy ferrous F33Y CuBMb complex in 15% glycerol/H2O buffer pH 10 Instrument conditions: 
2K, modulation amplitude 2G; rf pozer 5W, scan  rate 1MHz/s; frequency bandwidth 60kHz; average of 20 
scans. 
To gain further insight into oxygen reduction by F33Y-CuBMb, we monitored the decay of 
the above cryoreduced species by annealing. As previously reported, annealing the cryoreduced 
oxy-wtMb at 190K converts the peroxo signal with gmax = 2.22 to the more rhombic EPR signal of a 
ferric-hydroperoxo intermediate, with g = [2.32, 2.18, 1.93] (Figures 2.9 and 2.10), through 
protonation of the peroxo moiety. Upon annealing of cryoreduced oxy-F33Y-CuBMb at 173-175K for 
at least 1 minute, a signal with g = [2.34, 2.19, 1.94] begins to appear and continues to grow in at 
190K (Figures 2.9, 2.10, and 2.11). These EPR parameters are very similar to those of ferric-
hydroperoxo-wtMb. Appearance of this signal during annealing is interpreted to arise both from 
protonation of the ferric-peroxo centers with gmax = 2.24 to form ferric-hydroperoxo, and by 
relaxation/repositioning of the hydroperoxo ligand of the gmax = 2.29 species of the heme iron 
(Figure 2.9). 
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Based on the known reactivity of the (hydro)peroxo-hemes, these intermediates are 
expected to thermally decompose to the compound II (CpdII), a ferryl species that is EPR silent. 
Consistent with this prediction, upon further annealing both samples at 210K and 220K (Figures 2.9 
and 2.10), we observed obvious decay of the (hydro)peroxo signals to an EPR silent state. It has been 
shown previously that further cryoreduction of the EPR silent CpdII (Fe(IV)=O2-) at 77 K generates 
a low spin rhombic EPR signal from the Fe(III)-O2- or Fe(III)-OH- species, depending on the 
protonation state of ferryl precursor. Subsequent cryoreduction of the above EPR-silent species in 
wtMb resulted in a signal with gmax = 2.43 and gmin = 1.93 (Figure 2.13), characteristic of Fe(III)-O2- 
(ferric oxo) species observed in cryoreduced CpdII (g = [2.43, 2.12, 1.93]),50 thereby confirming that 
the EPR silent state arising after annealing of (hydro)peroxo-wtMb as the Fe(IV)=O2- CpdII. A minor 
signal with gmax = 2.52 and gmin = 1.90 (Figure 2.13) was also observed, previously assigned as 
protonated ferric-oxo, i.e. ferric-hydroxo (Fe(III)-OH-).50 
 
Figure 2.13. EPR spectra of oxy-ferrous proteins after cryoreduction-annealing-cryoreduction. 
In the case of F33Y-CuBMb, further cryoreduction of the EPR annealed silent species yielded 
a dominant EPR signal with g = [2.52, 2.15, 1.90] (Figure 2.13), likewise assigned as ferric-hydroxo. 
This result supports the hypothesis that the hydroperoxo-F33Y-CuBMb converts to CpdII, as in 
wtMb. The assignment of these species is confirmed by comparison with the same signals observed 
in cryoreduced samples of CpdII in both proteins generated by reaction with H2O2 at ambient 
temperature (Figure 2.14). 
The observation of two distinct signals in cryoreduced oxy-F33Y CuBMb at 77K suggests the 
presence of two structural states of the oxy-ferrous precursor. The peroxo signal with g = [2.24, 2.13, 
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1.95] is nearly identical to the signal observed in wtMb, and well within the range of other oxygen 
binding proteins such as hemoglobin,37,38 suggesting that the oxy-ferrous population leading to this 
state has similar interactions and behaves in a similar manner. On the other hand, the observation 
of a hydroperoxo species with g = [2.29, 2.17, 1.96] at 77K requires a configuration of the oxygen in 
which it can be easily protonated at 77K (Figure 2.9). The observation of protonated Fe(III)-OH- in 
F33Y-CuBMb upon subsequent cryoreduction of annealed species provides further support for the 
facile protonation of intermediates. 
 
Figure 2.14. EPR spectra of hydrogen peroxide formed Cpd(II) in wtMb and F33Y CuBMb after cryoreduction. 
2.3.2. Crystal structure of oxy-F33Y CuBMb 
Previous cryoreduction studies of a variety of oxy-hemeproteins25,30,39-43,47,49 showed that 
proton transfer to a cryoreduced oxy-heme at 77K requires the presence of an extended H-bonded 
proton delivery network in the oxy-ferrous protein that includes protic residues and at least one 
ordered water molecule H-bonded to the terminal oxygen atom of the dioxygen ligand. Based on 
these observations, we hypothesize that the F33Y-CuBMb may contain a similar H-bonding network 
for faster delivery of protons to the oxy-heme than in wtMb. 
To test this hypothesis, we obtained the crystal structure of oxy-F33Y-CuBMb. The oxy-F33Y-
CuBMb crystal was prepared using an established method of soaking ferric-Mb crystals in dithionite, 
followed by exposure to oxygen.52 A UV-Vis spectrum of this single crystal prior to diffraction 
confirmed spectral features indicative of oxy-protein (Figure 2.15). This oxy-F33Y-CuBMb structure 
refined at 1.27 Å resolution is shown in Figure 2.16, compared with the structure of oxy-wtMb. An 
omit-map showing the electron density of the oxygen ligand is shown in Figure 2.17. While the 
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refinement of this structure yielded an incomplete occupancy for the oxygen ligand, likely due to 
the reduced affinity of F33Y-CuBMb for oxygen, this structure nevertheless provides a foundation 
supporting the above interpretation of the EPR data. As suggested by the EPR results, an extended 
H-bonding network involving two water molecules is present in oxy-F33Y-CuBMb, with W1 
stabilized by H-bonds with the engineered His43 and Tyr33 residues, and W2 stabilized by H-bonds 
to W1 and the engineered His29 (Figure 2.16). Together, this H-bonding network creates H-bonding 
interactions between W2 and the distal oxygen atom of bound oxygen, as postulated above. 
Furthermore, as a result of these changes in the active site pocket, the oxygen atom in F33Y-CuBMb 
is rotated from that in wtMb by ~13° about the Fe-O bond, apparently to maximize its ability to 
accept hydrogen bonds from His64 and W2. Such an interaction of the oxygen with the W2 would 
be expected to enable the facile protonation, by W2, of the peroxo intermediate formed on 
cryoreduction at 77K, yielding the hydroperoxo observed by the cryogenic EPR results.  
 
 
Figure 2.15. Single crystal microfocus electronic absorption spectrum of the oxy-ferrous F33Y CuBMb crystal. 
 
Figure 2.16. Crystal structure of oxy-F33Y-CuBMb determined at 1.27 Å resolution, in comparison with that 
of oxy-wtMb (1A6M).53 Alternative W2 position shown translucent. 
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Figure 2.17. 2Fo - Fc map (gray) and omit map before building oxygen and W2 (green) of distal pocket of oxy-
F33Y CuBMb structure. Fe-O distance is 1.84 Å. 
2.3.2.1. EPR characterization of cryoreduced oxy-CuBMb and oxy-G65Y-CuBMb.  
In order to obtain a more complete understanding of oxygen reduction by the family of 
CuBMb proteins, the EPR of cryoreduced oxy-ferrous protein was extended to CuBMb and G65Y-
CuBMb as well. Crystal structures of both of these proteins revealed similar hydrogen bonding 
networks to F33Y-CuBMb, and these would be expected to have similar but distinct EPR spectra.  
The EPR spectra of oxy-CuBMb and oxy-G65Y-CuBMb cryoreduced at 77K are shown in 
Figure 2.18, and their g-values are given in Table 2.2. Comparison with F33Y-CuBMb and wtMb 
clearly reveals that cryoreduced oxy-CuBMb and oxy-F33Y-CuBMb possess similar spectroscopic 
features. Minor shifts in the ERP signals are observed, most noticeably, the change in g-value of the 
hydroperoxo peak at 2.29 shifting to 2.28 in CuBMb upon annealing. Such a shift could be attributed 
to a minor rearrangement of the hydrogen bonding network, resulting in the proton on the 
hydroperoxo ligand engaging in a stronger hydrogen bond. While it cannot be stated with certainty 
why this occurs in CuBMb and not F33Y-CuBMb, it may be that the presence of Tyr33 and the 
additional water observed in the hydrogen bonding network of F33Y prevents locks the orientation 
of one of the water molecules and prevents reorganization of its hydrogen bonding interaction.  
G65Y-CuBMb reveals qualitatively similar results to the other CuBMb variants, with distinct 
differences. First, a fairly significant increase is observed in the gmax-values of the species formed 
immediately upon annealing. This is indicative of an environment that more strongly polarizes the 
iron-oxygen orbitals and consistent with strong hydrogen bond donation to the bound ligand. 
Secondly, the intensity and therefore population of the hydroperoxo signals is significantly lower 
41 
 
than in the other CuBMb mutants. This is unexpected, given that G65Y-CuBMb achieves faster rates 
of oxygen reduction with similar product ratios. However, it is also clear from crystal structures 
that G65Y-CuBMb engages in significantly different hydrogen bonding interactions than CuBMb 
and F33Y-CuBMb (Figures 2.6 and 2.7). Given that the configuration in which Tyr65 is displaced 
from the active site is expected to have a similar active site arrangement to CuBMb, it seems likely 
that, given the significant spectroscopic differences between the proteins, that G65Y-CuBMb does 
not adopt this configuration upon oxygen binding. Therefore, it seems likely that in oxy-G65Y-
CuBMb the His29 is displaced from the active site and can no longer engage in the hydrogen 
bonding network. It is also likely that substantial protonation of the peroxo intermediate at 
cryogenic temperatures requires the presence of His29 to achieve. However, given that G65Y-
CuBMb still achieves oxygen reduction with a similar product ratio to the other CuBMb proteins, it 
seems likely that the slight polarization observed is sufficient to inhibit ROS release and drive 
oxygen reduction to water (See Section 3.4.8 for further discussion of trends). 
 
 
Figure 2.18. EPR spectra of oxy-wtMb, oxy-CuBMb, oxy-F33Y-CuBMb, and oxy-G65Y-CuBMb after radiolytic 
reduction with a ~3Mrad dose of γ radiation from 60Co and subsequent stepwise annealing at indicated 
temperatures (sharp signal marked by asterisk is due to radiolytically generated hydrogen atoms at 77K in 
quartz EPR tube). 
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Table 2.2. ERP parameters of cryoreduced oxy-CuBMb and oxy-G65Y-CuBMb 
2.3.3. Conclusions 
Given the spectroscopic and crystallographic evidence for an H-bonding network that 
interacts with the O2 in oxy-F33Y-CuBMb, and its absence in oxy-wtMb (Figure 2.16), we infer that 
this H-bonding network is the important structural feature that has transformed wtMb, a protein 
that can only bind O2 reversibly, into F33Y-CuBMb, a protein that can activate O2 and reduce it to 
water. We propose that this activation is achieved by polarization of the O-O bond by the H-bonded 
water, allowing facile reduction and protonation of the oxygen and intermediates. While H-
bonding networks involving water have been observed in native heme enzymes such as 
cytochromes P45025,27,41,54-56 and a similar network has been proposed to occur in HCOs based 
computational and isotope studies,21-24 design of metalloenzymes to incorporate this important 
structural feature has been difficult to perform and to confirm. The combination of cryoreduction 
EPR spectroscopy and high-resolution crystallography presented in this work provides a clear 
example of the importance of H-bonding networks involving water in conferring activity to 
designed metalloenzymes. We believe this structural feature will be critical to enhancing the future 
success of high activity metalloenzyme design. 
2.4. Materials and methods 
2.4.1. Determination of Kd for F33Y-CuBMb and G65Y-CuBMb for copper 
F33Y-CuBMb and G65Y-CuBMb were titrated with increasing amounts of copper and 
monitored using UV-Visible spectroscopy using a previously described method57 to determine KD. 
The spectra were analyzed using the method described by Bidwai, A. et al.58  
2.4.2. EPR spectroscopy of Cu(II) titrations 
EPR samples were prepared by exchanging protein into fresh 100 mM KPi pH 7.0 and 
concentrating to ~400-500 μM. Sodium acetate or water were added from a stock to bring the 
acetate concentration to desired quantities. Copper sulfate was added from a stock, slowly in 4 
Protein g1 g2 g3 
CuBMb    
 peroxo  2.24 2.13 1.96 
 hydroperoxo1 2.28-2.29 2.16 1.96 
 hydroperoxo2  2.33 2.18 1.94 
G65Y-CuBMb    
 peroxo  2.25 2.13 1.96 
 hydroperoxo1  2.28-2.30 2.16 nd 
 hydroperoxo2  2.33 2.19 1.94 
1 Primary hydroperoxo product formed at 77K. 2 Hydroperoxo product formed upon annealing. 
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additions over 4 minutes, with stirring, on ice. Glycerol was mixed in to 30% final concentration. 
The solution was loaded into an EPR tube and flash frozen in liquid nitrogen. 
X-band EPR spectra were collected on a Varian E-122 spectrometer at the Illinois EPR 
Research Center (IERC). EPR spectra were recorded at 20K, a modulation frequency of 100 kHz, a 
modulation amplitude of 5 G, microwave power of 2 mW and with a sweep rate of 8.3 G/s. Spectra 
were recorded at microwave frequencies of approximately 9.364 GHz, Magnetic fields were 
calibrated with a Varian NMR gaussmeter, and the frequencies were measured with an EIP 
frequency counter. 
2.4.3. Cryoreduced oxy-ferrous EPR sample preparation 
Each protein was concentrated to ~1-3 mM concentration and reduced with excess 
dithionite anaerobically under nitrogen atmosphere. Dithionite was removed under anaerobic 
conditions by a small GE Sephadex G-25 desalting column. The protein was reconcentrated 
anaerobically. The protein solution was removed from the anaerobic chamber and immediately, 
slowly, and gently sparged with pure oxygen gas from a syringe. The protein was briefly centrifuged 
to remove bubbles and mixed with pure glycerol to yield 15% final glycerol concentration. This 
solution was quickly transferred to an EPR tube and slowly frozen with liquid nitrogen. 
Samples were transferred to a glass dewar filled with liquid nitrogen and irradiated with ~3 
Mrad of gamma radiation over 440 minutes using a Gammacell 220 irradiator containing a 60Co 
source. Irradiated samples were stored and transported in liquid nitrogen at all times. 
2.4.4. EPR/ENDOR spectroscopy – cryoreduced samples 
X-band CW EPR spectroscopy was performed using a Bruker ESP-300 spectrometer 
equipped with an Oxford Instruments ESR-900 helium flow cryostat. EPR spectra were recorded at 
20K, a modulation frequency of 100 kHz, a modulation amplitude of 5 G, microwave power of 2 mW 
and with a sweep rate of 10 G/s. Spectra were recorded at microwave frequencies of approximately 
9.364 GHz, with the precise microwave frequencies recorded for individual spectra using a Hewlett-
Packard Microvawe Frequency Counter (HP5352B). CW Q-band EPR/ENDOR spectra were 
recorded on a modified Varian E-109 spectrometer described previously.30,38,40 All CW Q-band 
EPR/ENDOR spectra were recorded at 2 K in dispersion mode, under “rapid passage” conditions, 
which gives absorption line shape. Derivative spectra were obtained numerically using program 
LabCalc. Asymmetry in the 1H ENDOR spectra commonly seen in the ENDOR spectra of 
cryoreduced oxyferroheme proteins is due to the effects of spin relaxation.30 
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2.4.5. Protein crystallography 
2.4.5.1. F33y-CuBMb crystallization 
Resting state (aquo-met-ferric) crystals of F33Y CuBMb were grown under conditions 
previously reported (for Cu(II) structure), or with slight optimizations detailed here (for subsequent 
crystals; see Appendix).59 Sitting drop vapor diffusion was utilized to increase drop size and allow 
for larger crystals. Protein was concentrated to 1 mM in 20 mM tris sulfate pH 8.0 buffer. 
Crystallization solution was composed of 100 mM sodium 2-(N-morpholino)ethansulfonate (MES) 
pH 6.75, 200 mM sodium acetate, and 30% w/v PEG 10,000. Solutions were mixed 1:1 to yield a final 
drop volume of 200 μL. This was equilibrated by vapor diffusion against 30 mL of crystallization 
solution, at 4°C, in dark. Crystals formed within 1 week. 
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2.4.5.2. G65Y-CuBMb crystallization – low resolution 
Met-G65Y-CuBMb was exchanged into fresh 20 mM tris sulfate pH 8.0 and concentrated to 
1.5 mM. The protein was mixed 1:1 with crystallization buffer consisting of 30 % PEG 10K, 100 mM 
tris sulfate pH 8.4, and 200 mM potassium acetate and crystallized by hanging drop vapor diffusion 
against this buffer. The crystals were cryoprotected with 50% PEG 400.  
Table 2.3. Data collection and refinement statistics for low resolution G65Y-CuBMb structures. 
 YL108-3 YL108-4 
Data Collection   
Source NSLS x29a NSLS x29a 
Date   
Detector ADSC Q315 ADSC Q315 
Wavelength (Å) 1.075 1.075 
   
Data Reduction   
Software HKL2000 v704u (Linux) HKL2000 v704u (Linux) 
Spacegroup P21 P21 
Unit cell (a x b x c; Å / β; °) 34.41 x 31.86 x 70.62 / 101.38 34.56 x 31.60 x 70.94 / 101.36 
Resolution range (highest shell) 50-2.20 (2.24-2.20) 50-2.30 (2.34-2.30) 
Overall B-factor, Wilson (Å2) 25.24 28.52 
Unique reflection 7791 (366) 6740 (293) 
Completeness (%) 99.7 (95.8) 98.0 (86.2) 
Redundancy 6.1 (8.7) 6.5 (4.7) 
<I/σ(I)> 11.5 6.3 
CC½ (0.968) (0.657) 
Rmerge 0.115 (0.224) 0.140 (0.753) 
Rpim 0.038 (0.111) 0.058 (0.372) 
Rmeas/rim 0.121 (0.282) 0.152 (0.844) 
   
Refinement   
Software Phenix v1.8.2_1309 (Linux) Phenix v1.8.4_1496 (Win) 
Resolution range (highest shell) 34.614-2.201 (2.289-2.201) 34.774-2.304 (2.536-2.304) 
Reflections 12982 (954) 5930 (939) 
Completeness (%) 87.03 (57) 45.66 (29) 
Free set (%; random) 10.13 10.17 
Rwork 0.1983 (0.2158) 0.2280 (0.2633) 
Rfree 0.2561 (0.3416) 0.2774 (0.3433) 
Molecules in ASU 1 1 
# of Atoms   
  Protein 1226 1212 
  Solvent 16 18 
  Other 43 43 
Ramachandran favored/disallowed (%) 98.7/0.0 97.33/0.00 
 
2.4.5.3. G65Y-CuBMb crystallization – high resolution 
G65Y-CuBMb was exchanged into 100 mM KPi pH8.0 and concentrated to 1.7 mM 
concentration. To this was added 5eq of potassium cyanide and after 10 min, the protein exchanged 
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into fresh 20 mM tris sulfate pH 8.0. This was concentrated back to 1.7 mM and used to set a hanging 
drop crystal screen tray. The protein crystal was found after ~6 months in dark at 4°C in a drop 
mixed 1:1 with 1.6 M sodium citrate tribasic dihydrate pH 6.5. No additional cryoprotectant was 
used. 
Table 2.4. Data collection and refinement statistics for high resolution G65Y-CuBMb structure. 
  
Data Collection  
Source NSLS x26c 
Date  
Detector ADSC Q315 
Wavelength (Å) 1.000 
  
Data Reduction  
Software HKL2000 (Linux) 
Spacegroup P212121 
Unit cell (a x b x c; Å) 39.61 x 48.41 x 77.69 
Resolution range (highest shell) 50-1.55 (1.58-1.55) 
Overall B-factor, Wilson (Å2)  
Unique reflection 22041 (899) 
Completeness (%) 98.5 (82.0) 
Redundancy 6.8 (4.5) 
<I/σ(I)> 28.0 
Rmerge 0.040 (0.097) 
  
Refinement  
Software Phenix v1.8.2_1309 (Linux) 
Resolution range (highest shell) 41.087-1.550 (1.570-1.550) 
Reflections 41107 (1208) 
Completeness (%) 98.22 (79) 
Free set (%; random) 9.12 
Rwork 0.1724 (0.1860) 
Rfree 0.2109 (0.2299) 
Molecules in ASU 1 
# of Atoms  
  Protein 1309 
  Solvent 168 
  Other 44 
Ramachandran favored/disallowed (%) 97.6/0.00 
 
2.4.5.4. Cu(II)-F33Y-CuBMb crystal preparation 
Small crystals of met-F33Y-CuBMb obtained from hanging drop crystallization were used 
soaked with 10 eq. CuSO4 in a solution of F33Y-CuBMb and well buffer consistent with the original 
drop conditions to avoid dissolving the crystals and subsequently with 15 eq. potassium cyanide, in 
a mixture of F33Y-CuBMb and well buffer using pH 7.0 sodium cacodylate. 
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2.4.5.5. Cu(II)-F33Y-CuBMb data collection and structure solving 
The crystals were first soaked briefly in cryoprotectant (30% polyethylene glycol 400) and 
were flash cooled in liquid nitrogen. The diffraction data sets summarized in Table 2.5 were 
collected at the National Synchrotron Light Source beamline X29A (Upton, NY) and were processed 
with HKL2000 software.60 
The crystal structure was solved by the molecular replacement method using MOLREP in 
the CCP4 Package.61 Initial refinement was performed using X-plor62 and SHELX’9763. The position 
of Tyr33 was rebuilt using the program O.64 Final refinement of Cu-F33Y-CuBMb were carried out 
with the aid of Refmac565 and Coot.66 
Table 2.5. Data collection and refinement statistics for Cu(II)-F33Y-CuBMb structure. 
    
Data Collection    
Source BNL x29a BNL x29a BNL x29a 
Wavelength (Å) 1.075 1.3880 1.3720 
    
Data Reduction    
Software HKL2000 (Linux) HKL2000 (Linux) HKL2000 (Linux) 
Spacegroup P212121 P212121 P212121 
Unit cell (a x b x c; Å) 39.73 x 48.29 x 77.69 39.68 x 48.18 x 77.48 39,69 x 48.19 x 77.51 
Resolution range (highest shell) 50-1.80 (1.86-1.80) 50-2.12 (2.20-2.12) 50-2.12 (2.20-2.12) 
Unique reflection 14457 8795 8976 
Completeness (%) 100.0 (100.0) 100.0 (99.9) 100.0 (100.0) 
<I/σ(I)> 23.3 (4.6) 35.9 (4.7) 23.3 (4.6) 
Rmerge 0.111 (0.637) 0.094 (0.584) 0.098 (0.628) 
    
Refinement    
Software Phenix, REFMAC (Linux)   
Resolution range (highest shell) 41.01-1.80 (1.84-1.80)   
Reflections 13729   
Rwork 0.199 (0.221)   
Rfree 0.247 (0.331)   
Molecules in ASU 1   
# of Atoms    
  Protein 1218   
  Solvent 48   
  Other 42HEM/1FE/1CU/4CU   
Average Isotropic B-factor    
  Protein 34.0   
  Solvent 36.5   
  Other 34.5/27.1/38.4/61.6   
ESD (ESU) 0.097   
Bond RMSD (Å) 0.019   
Angle RMSD (°) 3.182   
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2.4.5.6. Oxy-F33Y-CuBMb crystal preparation 
Large crystals of met-F33Y-CuBMb obtained from sitting drop crystallization were used. 
Reduction was carried out anaerobically. Several crystals were harvested into a small container. 
This was exchanged into an anaerobic atmosphere chamber (Coy) by 27 headspace purges, down 
to 8 inHg of vacuum each, in the antechamber. Subsequently, crystals we transferred to a small 
finely-fritted filter reservoir filled with degassed crystallization solution containing 20 mM 
dithionite. These crystals were allowed to soak for 10 minutes to reduce protein and eliminate 
residual oxygen. Soaking solution was gently removed from the reservoir through the frit using a 
syringe, driven by a syringe pump and connected with plastic tubing to the bottom of the filter 
reservoir. Solution was replaced by adding fresh degassed solution into the filter. This washing was 
repeated four times total. (See Appendix for detailed descriptions of apparatuses used). 
Simultaneously, an aliquot of crystallization solution was supersaturated with oxygen, by exposing 
to ~1500 psi of oxygen pressure in a steel bomb for ~30 min. Subsequently, deoxy crystals were 
harvested into small (~2 μL) drops on slides. Upon removing the slide from the anaerobic chamber, 
~30 μL of oxygen supersaturated crystallization solution was immediately added and the drop was 
gently mixed. Crystals were harvested, cryoprotected (50% PEG 400 supersaturated with O2), and 
cryocooled in LN2 1-3 minutes after exposure to oxygen. 
2.4.5.7. Oxy-F33Y-CuBMb data collection and structure solving 
Single crystal spectra were collected under cryogenic conditions at APS Sector 14 using an 
OceanOptics DH-2000-S light source, OceanOptics USB4000 diode array detector, 4DX microfocus 
optics, 10 μm source fiberoptic, and 200 μm collector fiberoptic.67 X-ray data collection was carried 
out on beamline 14-BM-C. Data reduction and scaling were performed in HKL2000.60 The structure 
was solved by isomorphous replacement with the backbone and heme of the resting state model, 
4FWX.59 R-free flags were copied from the 4FWX dataset and extended to the resolution of this 
dataset with random selection. Refinement was performed in Phenix.68 Model building was carried 
out in Coot.66 Sidechains and water molecules were rebuilt manually and iteratively with 
refinement. The O-O bond was restrained at 1.22Å. Graphics were generate with CCP4MG69 and 
VMD with Tachyon.70,71 
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Table 2.6. Data collection and refinement statistics for oxy-F33Y CuBMb structure. 
  
Data Collection  
Source APS 14-BM-C 
Date 2014-11-14 
Detector ADSC Q315 
Wavelength (Å) 0.9787 
  
Data Reduction  
Software HKL2000 v704u (Linux) 
Spacegroup P212121 
Unit cell (a x b x c; Å) 39.63 x 47.61 x 76.53 
Resolution range (highest shell) 50-1.27 (1.29-1.27) 
Overall B-factor, ML (Å2) 12.45 
Overall B-factor, Wilson (Å2) 12.98 
Unique reflection 39055 (1853) 
Completeness (%) 99.6 (94.8) 
Redundancy 4.4 (2.6) 
<I/σ(I)> 17.9 
CC½ (0.856) 
Rmerge 0.039 (0.329) 
Rpim 0.020 (0.229) 
Rmeas/rim 0.044 (0.404) 
  
Refinement  
Software Phenix v1.9-1692 (Linux) 
Resolution range (highest shell) 23.84-1.268 (1.286-1.268) 
Reflections 72950 (2356) 
Completeness (%) 98.35 (82) 
Free set (%; random) 4.76 
Rwork 0.146 (0.2218) 
Rfree 0.178 (0.2288) 
Molecules in ASU 1 
# of Atoms  
  Protein 1277 
  Solvent 243 
  Other 45 
Average Isotropic B-factor 18.362 
  Protein 16.69 
  Solvent 27.91 
  Other 12.94 
Standard Uncertainty (ML) 0.1100 
Bond RMSD (Å) 0.017 
Angle RMSD (Å) 2.097 
Ramachandran favored/disallowed (%) 97.5/0.0 
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CHAPTER 3  
EXTENDING HYDROGEN BONDING AND IMPROVING PROTONATION IN CuBMb § 
3.1. Proton delivery – hypothesis and design 
The secondary coordination spheres of metalloenzymes provide important interactions to 
bound substrates and intermediates during enzymatic turnover. In particular, hydrogen bonding 
interactions are involved in tuning side-chain pKa values, stabilizing water networks, and 
facilitating proton shuttling. For instance, heme-copper oxidases (HCOs), whose active site resides 
in a hydrophobic membrane protein, have evolved networks of hydrogen bonded water molecules 
for efficient delivery of protons into the active site, and across the membrane.1-5 Within the active 
sites of most known HCOs are protic residues and cofactor moieties, such as tyrosine and the 
hydroxyfarnesyl group of a and o-type hemes.1,3,6-9 Computational calculations suggest that these 
protic groups are responsible for proton shuttling between the end of the K-channel and the oxygen 
substrate during turnover, and that this function must be mediated by a network of water molecules 
within the active site.10-13 It is also known that the first two protons for oxygen reduction are 
delivered to the oxygen by the D-channel, which terminates in a glutamate near the CuB site.14 In 
cytochromes P450, which also activate oxygen for heterolytic O-O bond cleavage, hydrogen bond 
interactions between protic residues and the oxygen, mediated by water molecules, have been 
shown to be critical in proper oxygen activation.14,25-29 
The work in Chapter 2 has already discussed the important role that extensive hydrogen-
bonding networks likely play in imparting oxidase activity to CuBMb.15,16 Briefly, it was hypothesized 
that the presence of an extensive hydrogen binding network consisting of the introduced protic 
residues and – most importantly – mediated by water, is the critical feature that imparted oxygen 
reductase activity to myoglobin. The extension of the hydrogen bonding network by positioning 
Tyr at one of two different positions demonstrated a dramatic effect.15 While rational protein design 
has been extremely successful, it has largely focused on design of interactions directly to the 
substrate or cofactor.17-19 On the other hand, extended hydrogen bonding networks, particularly 
those mediated by water molecules are well known in natural enzymes; however, rational design of 
such water-mediated interactions in enzymes has been limited.20-22 Here we focus on improving the 
oxygen reduction activity of CuBMb and F33Y-CuBMb by rational extension of the water mediated 
                                                          
§ Portions of this chapter have been taken from the following manuscript: 
Petrik, I. D., Davydov, R., Kahle, M., Sandoval, B., Ädelroth, P., Hoffman, B., Lu, Y.; “Enhanced oxygen activation and O-O bond 
cleavage in Ile107Glu mutants of oxygen reductase enzymes engineered from sperm whale myoglobin” J. Am. Chem. Soc. (in 
preparation) 
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hydrogen bonding network in their active sites to promote oxygen activation and proton transfer. 
Based on the nominal reaction catalyzed by our designed oxidases, complete reduction of oxygen 
to water requires delivery of two external protons and electrons to promote the O-O bond cleavage 
step. Two structural features were pursued to improve rapid delivery of protons during catalytic 
turnover, based on known features of oxidases and monooxygenases, as well as based on chemical 
intuition: 1) extending the hydrogen bonding network out of the protein for facile delivery of 
protons during turnover, mimicking the K-channel of HCOs; 2) extending the hydrogen bonding 
network by introducing a carboxylate sidechain into the active site, inspired by the Glu residue at 
the end of the D-channel that is responsible for delivering the first two catalytic protons.  
3.2. Proton channel – F33Y-D2-CuBMb 
3.2.1. Design hypothesis 
In CcOs, two protons for complete catalytic turnover are delivered to the CuB site via a 
water-based hydrogen bonding proton channel called the K-channel (see Chapter 1 for more detail). 
This channel terminates with the hydroxyl groups of the tyrosine and the hydroxyfarnesyl moiety 
on the catalytic heme. In F33Y-CuBMb, a hydrogen bonding network of waters is observed between 
the heme Fe and Tyr33/His43. It was hypothesized that proton delivery could be facilitated by 
extending this channel through the protein to bulk solvent, to mimic the structure and function of 
the K-channel. Structural analysis revealed that the shortest route from Tyr33 to bulk solvent is 
achieved by going between the G-helix and BC-loop region of the protein. 
Analysis of this region of the protein reveals that the closest residue to the hydrogen 
bonding network in F33Y-CuBMb is Thr39. Since this residue is already capable of forming hydrogen 
bonds, it was left, and attention was turned to designing the remainder of the hydrogen bonding 
network leading from bulk solvent to Thr39. Structural analysis revealed that access to Thr39 by 
bulk solvent is blocked by residues His36 and Phe106. Initial designs, inspired by the D-channel of 
CcOs, incorporated two aspartate residues at these positions. Modeling suggested that these groups 
could stabilize a channel of water molecules between helix G and loop BC. 
59 
 
 
Figure 3.1.  Molecular model of designed F33Y_D2-CuBMb “proton channel” 
3.2.2. Engineering and activity assays 
The F106D and H36D mutations were introduced into F33Y-CuBMb by site directed 
mutagenesis and the protein was purified from inclusion bodies (see Appendix A). The mutagenesis 
was confirmed by ESI-MS. The yield of this protein was remarkably low. The results of activity 
assays are shown in Figure 3.2. Unfortunately, this construct yielded lower activity than the parent 
F33Y-CuBMb with comparable effect of catalase (indicating similar amounts of H2O2 release; see 
Appendix). It was hypothesized that introduction of two negatively charged residues in close 
proximity destabilized the scaffold. 
 
Figure 3.2. Oxygen reduction catalyzed by F33Y_D2-CuBMb compared with F33Y-CuBMb. 
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3.3. Proton channel – 2Ser-F33Y-CuBMb 
3.3.1. Design rationale and hypothesis 
In order to improve on the design of the proton channel, residues were chosen at F106 and 
H36 that were predicted to cause less interference with each other. Serine was chosen due to its 
small protic nature. Molecular dynamics simulations were carried out and supported the possible 
formation of a hydrogen bonding network between bulk solvent and the active site pocket, through 
Thr39 (Figure 3.3). This protein, called 2S-F33Y-CuBMb was engineered, purified, and characterized. 
 
Figure 3.3. Molecular model of proposed design of 2S-F33Y-CuBMb. 
3.3.2. Engineering and basic characterization 
The F106S and H36S (and T39V, discussed later) mutations were introduced into F33Y-
CuBMb by site directed mutagenesis and the protein was purified from inclusion bodies (see 
Appendix A). The mutagenesis was confirmed by ESI-MS. Yield of this protein was lower than of 
F33Y-CuBMb, but reasonable. The absorption spectrum of this protein is shown in Figure 3.4. The 
features are typical of high-spin ferric protein,23 with a soret at 408 nm with an extinction coefficient 
ε408 = 136 mM-1. 
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Figure 3.4.  Electronic absorption spectra of 2S-F33Y-CuBMb (solid) and 2S-T39V-CuBMb (dashed). 
3.3.3. Activity assays 
The effect of the mutations was characterized by oxygen reduction activity assays, as 
previously reported (Figure 3.5).15 These assays revealed a ~2-fold increase in total oxygen 
consumption rate, with roughly the same product ratio as F33y-CuBMb. In order to attempt to 
determine whether the mutations were functioning by forming an extended proton channel out of 
the active site, a knock-out study was performed. Since Thr39 is a native residue of Mb proposed to 
form part of the designed channel, this residue was mutated to a valine, which is effectively a single 
atom substitution of oxygen to carbon on the amino-acid side-chain. Such a substitution, while 
structurally minimal, would be expected to completely break the proposed 2S hydrogen bonding 
network. Incorporation of this mutation resulted in no change in rate, and in fact a slight increase 
in the ratio of water production, within error. A similar relative effect was observed in the T39V 
mutant of F33Y-CuBMb lacking the two Ser residues, suggesting that Thr39 and the 2S mutations 
are independent of each other (Figure 3.5). 
 
Figure 3.5. Rates of oxygen consumption by indicated mutants to form either water (blue) or reactive oxygen 
species (red). 
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3.3.4. Discussion 
It is not entirely clear why the 2S mutations result in doubling of the oxygen consumption 
rate of F33Y CuBMb. In wtMb crystal structures, Phe106 and His36 form a pi-stacking interaction 
that may impart inter-helix stability. It is proposed that the effect of 2S mutations may be due to a 
general destabilization of the inter-helix interactions between the G helix and the BC loop.  The 
three residues introduced in F33Y-CuBMb with respect to wtMb – His29, Tyr33, His43 – all reside 
on the B and C loops of the protein. An increase in the dynamics of these residues may be 
responsible for improving oxygen turnover rates. 
3.4. I107E-CuBMb 
3.4.1. Design hypothesis 
Alternative rational extension of the water mediated hydrogen bonding network of CuBMb 
an F33Y CuBMb was based on analysis of their crystal structures and inspiration from native 
terminal oxidases. While the K-channel, ending in the hydroxyfarnesyl group and tyrosine, is 
known to be important for delivering some catalytic protons, in fact, the first two catalytic protons, 
responsible for the O-O bond cleavage step, are delivered by the D-channel.14 This channel 
terminates in a Glu residue, which is critical for function. In Chapter 2, it was proposed that the 
presence of W1 in the active site and it’s interactions with active site residues is key for imparting 
complete oxidase activity.24 In order to improve this activity, I chose to incorporate an acidic residue 
into this hydrogen bonding network, based on the hypothesis that a negatively charged carboxylate 
group would stabilize hydronium or protonated histidine in the active site during turn over, which 
would be expected to improve oxygen activation – by donating stronger hydrogen bonds to the 
bound oxygen – facilitate intermediate protonation, and minimize release of ROS. Given the 
extensive mutagenesis already performed, the available locations to introduce glutamate were 
limited (Figure 1.6). Location and choice of mutation were based on visual analysis and basic 
modeling in PyMol. The I107E mutation showed the best interaction with W1, with minimal 
perturbation of the active site (Figure 3.6). As discussed in Chapter 1, I017E was also found to 
improve nitrous oxide production in FeBMb, proposed to be due to improved protonation,25 further 
inspiring my choice of mutation. 
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Figure 3.6. Design of I107E CuBMb hydrogen bonding network. 
3.4.2. Basic characterization 
Proper incorporation of the I107E mutation into CuBMb and F33Y-CuBMb was confirmed by 
sequencing and mass spectrometry. As purified, the proteins displayed a soret peak at 408nm and 
a visible spectrum indicative of a high spin ferric state, and consistent with the aquo-ferric (met) 
resting state of Mb (Figure 3.7).23 The extinction coefficients of the soret peak in the resting states 
of I107E-CuBMb and I107E-F33Y-CuBMb are 181 mM-1 and 175 mM-1, respectively, consistent with 
high-spin ferric myoglobin.23 
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Figure 3.7. Resting state spectra of I107E-CuBMb and I107E-F33Y-CuBMb. 
3.4.3. Crystallography 
The successful incorporation of a carboxylate group into the water-containing hydrogen 
bonding network of CuBMb in I107E mutants was confirmed by X-ray crystallography. The crystal 
structures of the resting states of I107E-CuBMb and I107E-F33Y-CuBMb were determined at 1.67 Å 
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and 1.47 Å resolution, respectively (Figure 3.8). In both structures, as in previous structures of 
CuBMb variants, the active site contains a water molecule coordinating the heme (W0), which 
engages in a hydrogen bond with His64, and a second water molecule near His29 (W1), which 
engages in a hydrogen bond with W0 and His29. As desired in our design of the I107E variant, W1 
near His29 is also engages in a hydrogen bond with Glu107. Having shown that, at least in the 
resting state, the engineered Glu107 engages the hydrogen bonded water network in the desired 
manner, we proceeded to investigate its effect on the functional properties of the engineered 
oxygen reductase enzymes. 
 
 
Figure 3.8. Crystal structures of (A) I107E CuBMb and (B) I107E F33Y CuBMb, in their resting aquoferric (met) 
states. 
3.4.4. Oxygen reduction assays 
The oxygen consumption activities of both I107E-CuBMb and I107E-F33Y-CuBMb are shown 
in Figure 3.9, as compared with their Ile107 counterparts.15 As intended by the design, in both cases, 
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the I107E mutation has resulted in effective elimination of ROS release. The rate of water formation 
of CuBMb was roughly doubled by the I107E mutation. The I107E mutation did not increase the rate 
of water production of F33Y-CuBMb.  
Interestingly, the raw oxygen consumption traces as a function of oxygen concentration for 
I107E mutants showed rate beginning to saturate at lower oxygen concentrations than in their 
parent variants (Figure 3.10), suggesting that the I107E mutation imparts enhanced oxygen affinity. 
This was confirmed by measuring the oxygen affinities of these variants (Table 3.1 and Figure 3.11), 
which indeed showed that the I107E mutation resulted in substantial increases in oxygen affinity 
for both proteins. Previous studies at tuning the oxygen binding affinity of myoglobin have shown 
that mutations to Leu29 and Ile107 are critical for tuning oxygen affinity,26-28 although, typically 
increased oxygen affinity has been associated with larger hydrophobic sidechains and water 
exclusion in this region. The observation of increase in affinity with the introduction of a charged 
sidechain is noteworthy. Furthermore, it is known that increased oxygen affinity slows auto-
oxidation and release of ROS from myoglobin,29 which may contribute to the cleanliness of oxygen 
reduction by our I107E variants. 
 
Figure 3.9. Rates of O2 consumption yielding water (blue) or reactive oxygen species (ROS) (red), measured 
and calculated as reported previously.15,30,31 Rates of CuBMb, F33Y CuBMb, have been reported previously15 
and are included here for visual comparison. 
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Figure 3.10. Oxygen consumption rate curves as a function of oxygen concentration. 
Table 3.1. Oxygen affinities of myoglobin mutants 
Protein kon (μM-1 s-1) koff (s-1) Kd (koff/kon; μM) 
wtMb26 8.8 8.3 0.94 
CuBMb 0.04 9.4 235 
I107E-CuBMb 0.19 3.9 20.5 
F33Y-CuBMb 0.026 9.2 350 
I107E-F33Y-CuBMb 0.19 25.9 136 
 
 
Figure 3.11. Oxygen Kd plots for I107E CuBMbs 
3.4.5. EPR characterization of cryoreduced oxy-ferrous state 
In order to gain further understanding of how the introduced carboxylate residue tunes the 
reactivity of CuBMb and F33Y-CuBMb, I sought to probe the interactions of the oxygen bound to the 
active site, as performed on the original CuBMb variants in Chapter 2, using ERP spectroscopy of 
cryoreduced oxy-ferrous proteins. The EPR spectra of 77K cryoreduced oxy-CuBMb and oxy-F33Y-
CuBMb, and their I107E variants are shown in Figure 3.12 and their g-values are reported in Table 
3.2. As discussed in Chapter 2, Both CuBMb and F33Y-CuBMb spectra at 77K reveal two species. The 
EPR parameters of the first species, with gmax = 2.24 in both proteins, suggest that it is a ferric peroxo 
state in which the peroxo ligand engages in a hydrogen bond with the distal His64.35-38,46 The second 
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species with gmax = 2.29 in both proteins is in the range characteristic of ferric-hydroperoxo 
intermediates. Annealing of these two proteins at 199K leads to formation of a state with gmax = 2.34. 
This is proposed to be due to protonation of the gmax = 2.24 peroxo state and rearrangement of the 
gmax = 2.29 hydroperoxo state into a more rhombic hydroperoxo state. 
Results of EPR of cryoreduced oxy-I107E-CuBMb variants appear qualitatively similar, but 
reveal distinct differences. In both cases, the major peroxo signal produced at 77K is significantly 
more rhombic, with gmax = 2.27 in both proteins. Furthermore, the highly rhombic hydroperoxo 
signal with gmax = 2.32, which was not observed in CuBMb and F33Y CuBMb until they were annealed 
at 175K, is immediately observed at 77K in I107E variants. The lower rhombicity hydroperoxo ferric 
signal, gmax = 2.28-2.29, is observed as a shoulder of the major peroxo peak in both variants. The 
observation of these signals of much higher rhombicity than observed in the 77K spectrum of the 
parent proteins is a strong indicator of stronger hydrogen bond donation to and polarization of the 
bound O-O species. In the case of F33Y-CuBMb and I107E-F33Y-CuBMb, a minor signal is observed 
in I107E-F33Y-CuBMb that is consistent with the signals observed in F33Y-CuBMb. The presence of 
this mixture of signals in I107E-F33Y-CuBMb not observed in I107E-CuBMb may indicate a hysteresis 
of the water mediated hydrogen-bonding network due to an over-abundance of potential hydrogen 
bonding partners to W1. Nevertheless, the effect of the Glu107 still provides substantial benefit, 
driving the oxygen reduction reaction to lower ROS release (Figure 3.9). 
Table 3.2. EPR spectroscopic parameters of cryoreduced oxy- proteins. 
Protein g1 g2 g3 
CuBMb    
 peroxo 2.24 2.13 1.96 
 hydroperoxo1 2.29 2.16 1.93 
 hydroperoxo2 2.34 2.19 1.94 
F33Y CuBMb    
 Peroxo 2.24 2.13 1.96 
 hydroperoxo1 2.29 2.17 1.95 
 hydroperoxo2 2.34 2.19 1.94 
I107E CuBMb    
 Peroxo 2.27 2.16 1.96 
 hydroperoxo A1 2.29 2.20 nd 
 hydroperoxo B1 2.32 2.17 1.95 
I107E F33Y CuBMb    
 peroxo A 2.24            2.12 1.96 
 peroxo B 2.27 2.16 nd 
 hydroperoxo A1 2.28 2.17 nd 
 hydroperoxo B1 2.32 2.17 1.947 
 hydroperoxo C2 2.34 2.20 1.91 
1 Primary hydroperoxo product formed at 77K. 2 Hydroperoxo product formed upon annealing. 
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Figure 3.12.  Representative EPR spectra of oxy-CuBMb proteins after radiolytic reduction with a ~3Mrad dose 
of γ radiation from 60Co, and after subsequent stepwise annealing as indicated (sharp signal marked by 
asterisk is due to radiolytically generated hydrogen atoms at 77K in quartz EPR tube). 
To further understand the reactivities of I107E variants with oxygen, annealing of the 
samples was carried out. The full spectral series are shown in Figure 3.13 and a summary of the gmax 
signal intensities as a function of annealing is given in Figure 3.14. The first interesting feature 
observed was the immediate, nearly complete decay of the major peroxo signals in the I107E 
mutants after annealing at 145K for one minute. The decay of the peroxo signal is concomitant with 
the increase of the gmax = 2.32-2.34 hydroperoxo signal, indicative of conversion of the peroxo species 
into a hydroperoxo state, requiring protonation. This observation of rapid protonation of the major 
peroxo species at 145K to yield hydroperoxo is in stark contrast with the results of annealing of the 
parent proteins, and strongly supports the presence of a very labile proton in the active site. 
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Figure 3.13. Full EPR spectral sets of annealing experiments. 
Further careful annealing of the original CuBMb and F33Y-CuBMb proteins reveals that their 
peroxo and hydroperoxo states persist to about ~200K. Upon annealing at 200K for up to 200 min, 
the (hydro)peroxo species decay to an EPR silent state. In contrast, the (hydro)peroxo species of 
the I107E proteins begin to decay rapidly at 180K, and decay to an EPR silent state in less than 200 
min at this temperature (Figure 3.13 and 3.14). Consistent with previous results on myoglobin, 
subsequent cryoreduction of this EPR-silent state produces gmax = 2.54 signals consistent with ferric 
hydroxo (Fe(III)-OH). This confirms that (1) the EPR-silent state is the ferryl compound II 
(Fe(IV)=O; Figure 3.15), and furthermore that (2) the active site environment of I107E variants of 
CuBMb generally facilitates protonation of the Fe ligand. 
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Figure 3.14. Temperature dependence of the gmax peak intensity of the cryoreduced states, showing faster 
decay at lower temperatures in I107E mutants. 
The contrast between the decay kinetics of the (hydro)peroxo species of I107E and parent 
enzymes at cryogenic temperatures further supports the design hypothesis, that Glu107 stabilizes 
an additional proton in the active site, enabling the hydrogen bonding network to efficiently 
activate oxygen and quickly deliver two protons and promote heterolytic O-O bond cleavage during 
turnover.  
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Figure 3.15.  EPR spectrum of oxy-I107E-F33Y-CuBMb after cryoreduction-annealing-cryoreduction, showing 
ferric hydroxo signal. 
3.4.6. Crystal structure of oxy-I107E-CuBMb 
 
Figure 3.16. Structure of the active site of oxy-I107E-CuBMb at 1.18 Å resolution, with pertinent interatomic 
distances labeled. 
In order to gain further insight into the structural basis for oxygen activation of these 
efficient enzymes, we sought to obtain the crystal structure of the oxy- intermediate. Oxy-I107E-
CuBMb crystals were obtained as previously reported, by reducing ferric crystals, followed by rapid 
exposure to oxygen. The active site structure of oxy-I107E-CuBMb, solved at 1.18 Å resolution, is 
shown in Figure 3.16. While the occupancy of the dioxygen atom is incomplete, likely due to large 
crystals and short soak times, the structure still provides a structural basis for understanding the 
role of Glu107. As expected from design, a water molecule is present within hydrogen bonding 
distance of the bound dioxygen, and furthermore, this water molecule engages in hydrogen bonds 
with Glu107 and His29. The geometry of the hydrogen bonding interactions with oxygen is close to 
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ideal, suggesting that they do likely polarize the oxygen bond and could facilitate reduction and O-
O bond cleavage. 
3.4.7. Characterization of I107E-G65Y-CuBMb. 
Inspired by the success of the I107E mutation in CuBMb and F33Y-CuBMb, I also investigated 
if the same effect could be achieved in G65Y-CuBMb. I107E-G65Y-CuBMb was expressed and purified 
as previously reported. Oxygen consumption assays (Figure 3.17) show an elimination of ROS 
release, consistent with the results obtained for I107E-CuBMb and I107E-F33Y-CuBMb, although an 
overall decrease in the rate of oxygen consumption is observed. Oxygen affinity measurements 
(Figure 3.18 and Table 3.3) reveal that I107E increased the oxygen affinity of G65Y-CuBMb from Kd 
= 81 to 50.6 μM. 
EPR spectra (Figures 3.19 and 3.20), parameters (Table 3.3), and annealing decay traces 
(Figure 3.21) of G65Y-CuBMb and I107E-G65Y-CuBM are shown below. The effect of the I107E 
mutation on G65Y-CuBMb is similar to the effect observed in CuBMb. First, the parent peroxo 
species is more rhombic, with gmax = 2.29. Again, the high-rhombicity hydroperoxo species is 
observed immediately at 77K, indicating facile protonation, as observed in I107E-CuBMb and I107E-
F33Y-CuBMb. Furthermore, the complete decay of (hydro)peroxo signals at 180K is also observed. 
These results all suggest that the effect of I107E on G65Y-CuBMb is the same as observed in I107E-
CuBMb and I107E-F33Y-CuBMb. 
 
Figure 3.17. Oxygen consumption of G65Y-CuBMb and I107E-G65Y-CuBMb. 
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Figure 3.18. Oxygen binding plot for I107E-G65Y-CuBMb. 
Table 3.3. Oxygen binding properties of I107E-G65Y-CuBMb and G65Y-CuBMb. 
Protein kon (μM-1 s-1) koff (s-1) Kd (koff/kon; μM) 
G65Y-CuBMb 0.46 37.5 81 
I107E-G65Y-CuBMb 0.35 17.7 50.6 
 
Figure 3.19. EPR spectra of G65Y-CuBMb and I107E-G65Y-CuBMb  
 
Figure 3.20. EPR annealing kinetics spectra. 
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Figure 3.21. Temperature dependence of the gmax peak intensity of the cryoreduced states of G65Y-CuBMb 
and I107E-G65Y-CuBMb, showing faster decay at lower temperatures in I107E mutant. 
3.4.8. Trends of oxygen polarization and oxygen reduction by CuBMbs. 
Given the large quantity of cryo-reduction EPR and oxygen reduction activity data obtained 
through these investigations, we sought to identify trends that may help guide general principles 
of improving oxygen reduction. The strongest trend that was observed was between the rhombicity 
of the primary peroxo species and the ratio of water released vs. ROS (Figure 3.22). It is seen that as 
the rhombicity of this signal increases, the amount of ROS released decreases, down to 0%. 
Therefore, it is postulated that polarization of the bound dioxygen is a key determinant in whether 
oxygen reduction proceeds to completeness or results in release of ROS. 
 
Figure 3.22.  The apparent co-variance of water/ROS ratio of oxygen reduction products with the 
rhombicity of the primary peroxo EPR signal. 
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3.4.9. Conclusion 
Taken together, the results above demonstrate that the extension of the hydrogen bonding 
network within the active site of our designed oxidase myoglobin by introduction of Glu107 
facilitates protonation of intermediates and improves oxygen binding, resulting in cleaner oxygen 
reductase chemistry, by eliminating ROS release. It is postulated that this is a result of Glu107 
engaging in strong hydrogen bonds with the active site water network, stabilizing protons in the 
active site (Figure 3.23), which are then available for efficient oxygen polarization, activation, and 
protonation during turnover. These results support the role of the D-channel-terminating Glu 
residue in providing protons to the bound dioxygen during the first steps of oxygen reduction. 
Moreover, the results presented here and in Chapter 2, extensively characterizing the hydrogen 
bonding networks of 7 different variants of Mb, clearly demonstrate that designing long-range, 
water-mediated hydrogen-bonding networks – a feature that has seen some but, minimal pursuit 
in rational enzyme design strategies – can play a key role in determining enzymatic function, and 
should be pursued more actively in contemporary enzyme design strategies. 
 
Figure 3.23.  Schematic representation of the proposed differences in interactions between I107E and parent 
CuBMbs that results in cleaner oxygen reductase chemistry in I107E mutants. 
3.5. Materials and methods 
3.5.1. Molecular modeling 
Modeling of 2S-F33Y-CuBMb was carried out with the help of molecular dynamics 
simulations carried out in NAMD.32 The crystal structure of F33Y-CuBMb was used as the starting 
model, and the crystallographic water molecules in the heme were kept. Mutations were made 
using PSFGEN. Standard CHARMM33 topology and parameter files were used. The water box size 
was at least 3 times the size of the protein in each direction. Simulation was carried out with 5000 
steps of minimization, followed by 1 ns of dynamics. 
Modeling of I107E-CuBMb was done simply by using the mutate feature of pymol34 and 
seeing that a conformer of Glu at position 107 would engaging in a hydrogen bond with the water 
in the active site. 
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3.5.2. Oxygen affinity assays 
Oxygen affinity was determined by flash methods in which CO was flashed off in the 
presence of O2 to measure kon, and koff was measured directly. 
3.5.3. Crystallization, I107E-CuBMb 
Resting state (aquo-met-ferric) crystals of I107E-CuBMb were grown under modified 
conditions previously reported.15 Sitting drop vapor diffusion was utilized to increase drop size and 
allow for larger crystals. Protein was concentrated to 1.5-2.0 mM in 20 mM tris sulfate pH 8.0 buffer. 
Crystallization solution was composed of 100 mM tris sulfate pH 8.6, 200 mM sodium acetate, and 
30% w/v PEG 10,000. Solutions were mixed 1:1 to yield a final drop volume of 150-200 μL. This was 
equilibrated by vapor diffusion against 30 mL of crystallization solution, at 4°C, in dark. Crystals 
formed within 1 week. Two crystal forms were observed – long needles which diverged into fan 
shapes (P21) and thicker rectangular crystals (P212121). The orthorombic crystal form was propagated 
by seeding new crystallization drops. 
3.5.4. Crystallization, I107E-F33Y-CuBMb 
Resting state (aquo-met-ferric) crystals of I107E-CuBMb were grown under modified 
conditions previously reported.15 Sitting drop vapor diffusion was utilized to increase drop size and 
allow for larger crystals. Protein was concentrated to 1.5-2.0 mM in 20 mM tris sulfate pH 8.0 buffer. 
Crystallization solution was composed of 100 mM tris sulfate pH 8.6, 200 mM sodium acetate, and 
30% w/v PEG 10,000. Solutions were mixed 1:1 to yield a final drop volume of 150-200 μL. This was 
equilibrated by vapor diffusion against 30 mL of crystallization solution, at 4°C, in dark. Crystals 
formed within 1 week. 
3.5.5. Crystal preparation, oxy-I107E-CuBMb 
Oxy-I107E CuBMb crystals were prepared by anaerobic reduction and exposure to oxygen, 
based on previously reported methods.35,36 Several orthorhombic crystals were harvested into a 
small container. This was brought into an anaerobic atmosphere chamber (Coy) by 27 headspace 
purges, down to 8 inHg of vacuum each, in the antechamber. Subsequently, crystals we transferred 
to a small finely-fritted filter reservoir, filled with degassed crystallization solution containing 20 
mM dithionite. These crystals were allowed to soak for 10 minutes to reduce protein and eliminate 
residual oxygen. Soaking solution was gently removed from the reservoir through the frit using a 
syringe, driven by a syringe pump and connected with plastic tubing to the bottom of the filter 
reservoir. Solution was replaced by adding fresh degassed solution into the filter reservoir. This 
washing was repeated four times total. Deoxy crystals were harvested into small (~2 μL) drops on 
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slides and sealed in a high pressure bomb. The bomb was removed from the chamber and 
immediately pressurized to ~1500 psi O2 for 1-10 minutes. The bomb was carefully vented over 30s 
and the crystal harvested after brief soak in O2 supersaturated cryoprotectant (50% PEG 400 
supersaturated with O2). 
3.5.6. Crystallography, general method 
Unless otherwise noted, X-ray diffraction data were collected under cryogenic conditions. 
Data reduction and scaling were carried out with HKL2000.37 Refinement was carried out in 
Phenix.38 Model building was carried out using Coot.39 Graphics were generated using VMD with 
Tachyon.70,71 
3.5.7. Crystallography, met-I107E-CuBMb 
X-ray diffraction data were collected on beamline x29 at NSLS. The structure was solved 
using molecular replacement using the structure of CuBMb (4FWZ). Sidechains and water 
molecules were rebuilt manually and iteratively with refinement. 
3.5.8. Crystallography, met-I107E-F33Y-CuBMb 
X-ray diffraction data were collected on beamline 21-ID-G at APS. The structure was solved 
by isomorphous replacement using the backbone and heme of a related model, 4FWX. R-free flags 
were copied from the 4FWX dataset and extended to the resolution of this dataset with random 
selection. Sidechains and water molecules were rebuilt manually and iteratively with refinement. 
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Table 3.4. Data collection and refinement statistics for oxy-F33Y CuBMb structure. 
   
Sample I107E-CuBMb I107E-F33Y-CuBMb 
   
Data Collection   
Source NSLS x29 APS 21-ID-G 
Date 2014-08-23 2013-06-03 
Detector ADSC Q315r-906 MAR 300 CCD 
Wavelength (Å) 1.075 0.9786 
   
Data Reduction   
Software HKL2000 v2.3.8 (Linux) HKL2000 v2.3.1 (Linux) 
Spacegroup P21 P212121 
Unit cell (a x b x c; Å) 34.02 x 31.72 x 71.28 39.67 x 47.87 x 77. 88 
(β; °) 102.4 N/A 
Resolution range (highest shell) 50-1.70 (1.76-1.70) 50-1.48 (1.51-1.48) 
Overall B-factor, ML (Å2) 23.28 18.84 
Overall B-factor, Wilson (Å2) 25.02 20.18 
Unique reflection 16343 (1600) 25784 (1268) 
Completeness (%) 99.8 (98.5) 99.8 (99.9) 
Redundancy 7.6 (5.8) 3.8 (3.7) 
<I/σ(I)> 11.5 12.0 
CC½ (0.843) -- 
Rmerge/symm 0.073 (0.635) 0.047 (0.534) 
Rpim 0.025 (0.285) -- 
Rmeas/rim 0.077 (0.698) -- 
   
Refinement   
Software Phenix v1.10.1_2155 (Win) Phenix v1.8.2_1309 (Linux) 
Resolution range (highest shell) 34.82-1.708 (1.735-1.708) 20.48-1.467 (1.499-1.467) 
Reflections 31358 (1171) 48282 (2811) 
Completeness (%) 99.1 (83) 99.25 (93) 
Free set (%; random) 10 4.74 
Rwork 0.159 (0.262) 0.212 (0.313) 
Rfree 0.208 (0.305) 0.239 (0352) 
Molecules in ASU 1 1 
# of Atoms   
  Protein 1237 1274 
  Heme 43 43 
  Solvent 114 121 
  Other 113 -- 
Average Isotropic B-factor 31.32 22.65 
  Protein 28.57 22.34 
  Heme 21.60 18.54 
  Solvent 41.30 27.36 
  Other 55.07 -- 
Standard Uncertainty (ML) 0.18 0.19 
Bond RMSD (Å) 0.017 0.004 
Angle RMSD (Å) 1.561 1.489 
Ramachandran favored/disallowed (%) 96.75/0.65 96.82/0.00 
 
79 
 
3.5.9. Crystallography, oxy-I107E-CuBMb 
Single crystal spectroscopic data and X-ray diffraction data were collected at SSRL beamline 
11-1. Data reduction and scaling was carried out with XDS, pointless, aimless, and truncate, 
automated using the script ‘autoxds’.40 The structure was solved by isomorphous replacement using 
the backbone and heme of a related model, 4FWX. R-free flags were copied from the 4FWX dataset 
and extended to the resolution of this dataset with random selection. Refinement was performed 
with Phenix38 and REFMAC.41 Sidechains and water molecules were rebuilt manually and iteratively 
with refinement. The O-O group was modeled as peroxide (PER), due to reduction by the X-ray 
beam. 
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Table 3.5. Data collection and refinement statistics for oxy-F33Y CuBMb structure. 
  
Sample Oxy-I107E-CuBMb 
  
Data Collection  
Source SSRL 11-1 
Date 2015-07-20 
Detector DECTRIS Pilatus 6M 
Wavelength (Å)  
  
Data Reduction  
Software XDS v2015-03-01 
Pointless v1.9.33 
Aimless v0.5.12 
Truncate v6.5.013 (Linux) 
Spacegroup P212121 
Unit cell (a x b x c; Å) 39.84 x 46.98 x 78.03 
Resolution range (highest shell) 39-1.18 (1.20-1.18) 
Overall B-factor, ML (Å2) 7.19 
Overall B-factor, Wilson (Å2) 11.18 
Unique reflection 47352 (1510) 
Completeness (%) 97.0 (63.4) 
Redundancy 3.9 (2.1) 
<I/σ(I)> 31.7 (4.1) 
CC½ (0.902) 
Rmerge/symm 0.024 (0.216) 
Rpim 0.013 (0.169) 
Rmeas/rim 0.028 (0.275) 
  
Refinement  
Software Phenix v1.10.1_2155 (Linux) 
Resolution range (highest shell) 39.02-1.18 (1.19-1.18) 
Reflections 86347 (1303) 
Completeness (%) 92.81 (41) 
Free set (%; random) 4.77 
Rwork 0.1555 (0.2329) 
Rfree 0.1874 (0.3038) 
Molecules in ASU 1 
# of Atoms  
  Protein 1238 
  Heme + Oxygen 45 
  Solvent 307 
Average Isotropic B-factor 17.48 
  Protein 15.33 
  Heme + Oxygen 10.46 
  Solvent 27.19 
Standard Uncertainty (ML) 0.10 
Bond RMSD (Å) 0.015 
Angle RMSD (Å) 1.722 
Ramachandran favored/disallowed (%) 97.42/0.00 
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3.5.10. Cryoreduced oxy-ferrous EPR sample preparation 
Each protein was concentrated to ~1-3 mM concentration and reduced with excess 
dithionite anaerobically under nitrogen atmosphere. Dithionite was removed under anaerobic 
conditions by a small GE Sephadex G-25 desalting column. The protein was reconcentrated 
anaerobically. The protein solution was removed from the anaerobic chamber and immediately, 
slowly, and gently sparged with pure oxygen gas from a syringe. The protein was briefly centrifuged 
to remove bubbles and mixed with pure glycerol to yield 15% final glycerol concentration. This 
solution was quickly transferred to an EPR tube and slowly frozen with liquid nitrogen. 
Samples were transferred to a glass dewar filled with liquid nitrogen and irradiated with ~3 
Mrad of gamma radiation over 440 minutes using a Gammacell 220 irradiator containing a 60Co 
source. Irradiated samples were stored and transported in liquid nitrogen at all times. 
3.5.11. EPR spectroscopy 
X-band CW EPR spectroscopy was performed using a Bruker ESP-300 spectrometer 
equipped with an Oxford Instruments ESR-900 helium flow cryostat. EPR spectra were recorded at 
20K, a modulation frequency of 100 kHz, a modulation amplitude of 5 G, microwave power of 2 mW 
and with a sweep rate of 10 G/s. Spectra were recorded at microwave frequencies of approximately 
9.364 GHz, with the precise microwave frequencies recorded for individual spectra using a Hewlett-
Packard Microwave Frequency Counter (HP5352B). 
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CHAPTER 4  
DESIGN OF A HEME-Fe4S4 SITE IN CcP TO MIMIC SiR AND NiR 
4.1. Background – SiR and NiR 
Sulfite and nitrite reductases (SiR and NiR) are two related classes of enzymes that perform 
the intensive 6 e- reductions of sulfite and nitrite directly to hydrogen sulfide and ammonia, 
respectively.1-5 In bacteria, SiRs play a crucial role in the Cys synthesis pathway. These reactions are 
catalyzed at a unique active site, consisting of a novel Cys-ligated, five-coordinate Fe tetrapyrrole 
cofactor, bridged via the Cys-ligand to a Fe4S4 cluster.1-9 Using this arrangement, these enzymes 
catalyze sulfite and nitrite reduction efficiently, without release of partially reduced intermediates.1-
5 It is believed that this unique coupled cofactor acts as a “molecular battery,” capable of rapid and 
complete 6e- reduction of the substrate, in clean 2e- or 3e- transfers.4,10-19 DFT calculations suggest 
that catalytic intermediates of SiRs/NiRs may be analogous to those of NO and O2 reducing 
enzymes.20 Therefore, given the success of our lab in engineering simplified enzymes with similar 
function to native enzymes to expand our understanding of that function, we sought to apply the 
biosynthetic to the design of the unique heterobimetallic heme-Fe4S4 site of SiR/NiR into the CcP 
scaffold.  
4.2. Design 
4.2.1. Scaffold selection 
The first criterion for scaffold selection was that the protein be crystallized and known to 
have a tetrapyrrole binding site. The MARKUS server21 identified the peroxidase fold as a promising 
fold due to the amount of space potentially available on the proximal side of the heme, if native 
sidechains are made smaller. Fortunately, the Lu lab has experience working with cytochrome c 
peroxidase (CcP)22-26 and has previously engineered the CuB center into CcP.26 Furthermore, CcP 
has been previously successfully mutated to have Cys ligation to the heme.23 Therefore, this scaffold 
was used for subsequent design. Prior to searching for how to incorporate the Fe4S4-cluster in the 
proximal pocket of the heme, molecular modeling was carried out to change the heme ligand to 
Cys, and this structure was used for subsequent work. 
4.2.2. RosettaMatch – “Theozyme” design 
The Rosetta suite, developed by David Baker and coworkers at University of Washington,27-
30 has proven extremely powerful in designing new proteins and enzymes.31-35 In particular, the 
RosettaMatch algorithm29 is an extremely powerful, thorough, and automated search protocol to 
identify sites, and corresponding mutations in a protein that can accommodate specific interactions 
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with a ligand. This was used to identify sites that could bind the transition states of the retro-aldol 
reaction32 and the Kemp-elimination,33 and to re-engineer natural proteins to carry out these un-
natural reactions. Here, we use this powerful tool to identify mutations that can allow the Fe4S4 
cluster to bind in the proximal pocket of the heme. 
In order to use RosettaMatch, the desired interactions of the cofactor with the protein must 
be defined. This definition is called a “theozyme” – short for theoretical enzyme, due to the fact 
that it typically describes the key minimal interactions that are expected to impart the desired 
enzymatic activity. In this case, the theozyme describes the allowable binding modes of the Fe4S4 
cluster with its ligands. In order to define the theozyme, the structure of native SiR was 
inspected.16,36,37 The structure of the Fe4S4 cluster itself was built by measuring the average Fe-Fe 
and S-S distances. The average Fe-Fe distance was measured as 2.78 Å and the average S-S distance 
as 3.70 Å. The cluster was obtained by building two tetrahedra with edge lengths corresponding to 
these distances, with Fe and S atoms at the vertices, and intersecting these to form a cuboid 
structure. The resulting Fe-S distances were 2.336 Å, which is roughly half way between the 
distances known for oxidized and reduced [Fe4S4] clusters. 
In SiR, the cluster is held in place by Cys coordination of each of the Fe vertices.16,36,37 The 
possible placements of the cluster were determined relative to the heme-ligating Cys. The 
constraints used to define these placements are shown graphically in Figure 4.1. To narrow down 
these placements, necessary interaction constraints with additional Cys residues were defined, 
including the Fe-S bond length and the Cβ-SCys-Fe and SCys-Fe-S angles. These are shown graphically 
in Figure 4.1. The constraints definition file is given in Materials and methods. 
 
Figure 4.1. Graphical depiction of constraints used to search for [Fe4S4] cluster binding site. 
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4.2.3. RosettaMatch – Results 
RosettaMatch was carried out using these constraints, searching within the proximal pocket 
of the heme scaffold. The first attempt, finding 4-Cys residues to bind the FeS cluster within the 
proximal pocket, was unsuccessful. Only 3 ligand constraints could be satisfied, but the program 
could not find a fourth. In order to determine whether and any of the intermediate hits might give 
viable starting points for manually designing the fourth ligand, RosettaMatch was rerun to look for 
only 3 ligands. Three hits were identified, however only one of these did not cause clashes with the 
heme – H175C/W191C/L232C (Figure 4.2). 
 
Figure 4.2. Best result of RosettaMatch attempt 2. 
4.2.4. MD simulations 
In order to identify the best place, if any existed, to build the fourth Cys ligand, the result 
of RosettaMatch was first be subject to molecular dynamics simulation to allow the structure to 
relax around the cluster. In order to carry out this simulation, the force field parameters for the 
Fe4S4 cluster and its interactions with the Cys residues and heme needed to be defined. These were 
derived from Chang and Kim,38 and the relevant parameters are given in Materials and methods. In 
order to make room for the cluster, residues 230 and 235 were additionally mutated to Val or Ala. 
The results of the best simulation are shown in Figure 4.3. 
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Figure 4.3. Structure of designed Fe4S4 site after RosettaMatch and making compensatory mutations. 
4.2.5. Manual design of final ligand 
After this simulation, it was identified that residue 180 could act as a Cys ligand to the 
[Fe4S4]-cluster if the backbone loop is allowed to move slightly. This mutation was made in silico 
and the resulting cluster site was simulated. The overlay of this designed site with the heme-[Fe4S4] 
site of native SiR shows relatively close structural agreement between the two (Figure 4.4). 
 
Figure 4.4.  Overlay of the final designed heme-Fe4S4 cluster site with the native site of SiR. 
4.3. Further experimental refinement and ERP characterization 
This construct has been engineered by mutagenesis and subject to basic characterization. 
Incorporation of the Fe4S4 cluster was carried out according to published techniques,39-42 and been 
confirmed by EPR spectroscopy (Figure 4.5).13 Activity assays and further characterization are 
actively underway.  
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Figure 4.5.  EPR spectra of H175C/T180C/W191C/M230A/L232C/D235V-CcP, reduced with dithionite. 
4.4. Materials and methods 
4.4.1. RosettaMatch constraint files 
Code 4.1. Constraints file for RosettaMatch attempt 1. 
CST::BEGIN 
  TEMPLATE::   ATOM_MAP: 1 atom_name: FE1 S4 FE2 
  TEMPLATE::   ATOM_MAP: 1 residue3: F4O 
 
  TEMPLATE::   ATOM_MAP: 2 atom_name: SG CB CA 
  TEMPLATE::   ATOM_MAP: 2 residue1: C 
 
  CONSTRAINT:: distanceAB:    2.40   0.30 100.00  1        2 
  CONSTRAINT::    angle_A:  106.00   6.00 100.00  360.00   1 
  CONSTRAINT::    angle_B:  170.00  10.00  50.00  360.00   2 
  CONSTRAINT::  torsion_A:  000.00  10.00  50.00   10.00   0 
  CONSTRAINT::  torsion_B:  000.00  60.00  25.00  360.00   6 
  CONSTRAINT:: torsion_AB:  000.00  10.00   0.00   10.00   0 
   
  ALGORITHM_INFO:: match 
    CHI_STRATEGY:: CHI 1 EX_FOUR_HALF_STEP_STDDEVS 
 IGNORE_UPSTREAM_PROTON_CHI 
  ALGORITHM_INFO::END 
   
CST::END 
 
CST::BEGIN 
  TEMPLATE::   ATOM_MAP: 1 atom_name: FE2 S3 FE1 
  TEMPLATE::   ATOM_MAP: 1 residue3: F4O 
 
  TEMPLATE::   ATOM_MAP: 2 atom_name: SG CB CA 
  TEMPLATE::   ATOM_MAP: 2 residue1: C 
 
  CONSTRAINT:: distanceAB:    2.40   0.30 100.00  1        2 
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  CONSTRAINT::    angle_A:  106.00   6.00 100.00  360.00   1 
  CONSTRAINT::    angle_B:  170.00  10.00  50.00  360.00   2 
    
  ALGORITHM_INFO:: match 
    CHI_STRATEGY:: CHI 1 EX_FOUR_HALF_STEP_STDDEVS 
 IGNORE_UPSTREAM_PROTON_CHI 
 SECONDARY_MATCH: DOWNSTREAM 
  ALGORITHM_INFO::END 
   
CST::END 
 
CST::BEGIN 
  TEMPLATE::   ATOM_MAP: 1 atom_name: FE3 S2 FE1 
  TEMPLATE::   ATOM_MAP: 1 residue3: F4O 
 
  TEMPLATE::   ATOM_MAP: 2 atom_name: SG CB CA 
  TEMPLATE::   ATOM_MAP: 2 residue1: C 
 
  CONSTRAINT:: distanceAB:    2.40   0.30 100.00  1        2 
  CONSTRAINT::    angle_A:  106.00   6.00 100.00  360.00   1 
  CONSTRAINT::    angle_B:  170.00  10.00  50.00  360.00   2 
    
  ALGORITHM_INFO:: match 
    CHI_STRATEGY:: CHI 1 EX_FOUR_HALF_STEP_STDDEVS 
 IGNORE_UPSTREAM_PROTON_CHI 
 SECONDARY_MATCH: DOWNSTREAM 
  ALGORITHM_INFO::END 
   
CST::END 
 
CST::BEGIN 
  TEMPLATE::   ATOM_MAP: 1 atom_name: FE4 S1 FE1 
  TEMPLATE::   ATOM_MAP: 1 residue3: F4O 
 
  TEMPLATE::   ATOM_MAP: 2 atom_name: SG CB CA 
  TEMPLATE::   ATOM_MAP: 2 residue1: C 
 
  CONSTRAINT:: distanceAB:    2.40   0.30 100.00  1        2 
  CONSTRAINT::    angle_A:  106.00   6.00 100.00  360.00   1 
  CONSTRAINT::    angle_B:  170.00  10.00  50.00  360.00   2 
    
  ALGORITHM_INFO:: match 
    CHI_STRATEGY:: CHI 1 EX_FOUR_HALF_STEP_STDDEVS 
 IGNORE_UPSTREAM_PROTON_CHI 
 SECONDARY_MATCH: DOWNSTREAM 
  ALGORITHM_INFO::END 
   
CST::END 
  
Code 4.1. (cont.) 
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Code 4.2. Constraints file for RosettaMatch attempt 2. 
CST::BEGIN 
  TEMPLATE::   ATOM_MAP: 1 atom_name: FE1 S4 FE2 
  TEMPLATE::   ATOM_MAP: 1 residue3: F4O 
 
  TEMPLATE::   ATOM_MAP: 2 atom_name: SG CB CA 
  TEMPLATE::   ATOM_MAP: 2 residue1: C 
 
  CONSTRAINT:: distanceAB:    2.40   0.30 100.00  1        2 
  CONSTRAINT::    angle_A:  106.00   6.00 100.00  360.00   1 
  CONSTRAINT::    angle_B:  170.00  10.00  50.00  360.00   2 
  CONSTRAINT::  torsion_A:  000.00  10.00  50.00   10.00   0 
  CONSTRAINT::  torsion_B:  000.00  60.00  25.00  360.00   6 
  CONSTRAINT:: torsion_AB:  000.00  10.00   0.00   10.00   0 
   
  ALGORITHM_INFO:: match 
    CHI_STRATEGY:: CHI 1 EX_FOUR_HALF_STEP_STDDEVS 
 IGNORE_UPSTREAM_PROTON_CHI 
  ALGORITHM_INFO::END 
   
CST::END 
 
CST::BEGIN 
  TEMPLATE::   ATOM_MAP: 1 atom_name: FE2 S3 FE1 
  TEMPLATE::   ATOM_MAP: 1 residue3: F4O 
 
  TEMPLATE::   ATOM_MAP: 2 atom_name: SG CB CA 
  TEMPLATE::   ATOM_MAP: 2 residue1: C 
 
  CONSTRAINT:: distanceAB:    2.40   0.30 100.00  1        2 
  CONSTRAINT::    angle_A:  106.00   6.00 100.00  360.00   1 
  CONSTRAINT::    angle_B:  170.00  10.00  50.00  360.00   2 
    
  ALGORITHM_INFO:: match 
    CHI_STRATEGY:: CHI 1 EX_FOUR_HALF_STEP_STDDEVS 
 IGNORE_UPSTREAM_PROTON_CHI 
 SECONDARY_MATCH: DOWNSTREAM 
  ALGORITHM_INFO::END 
   
CST::END 
 
CST::BEGIN 
  TEMPLATE::   ATOM_MAP: 1 atom_name: FE3 S2 FE1 
  TEMPLATE::   ATOM_MAP: 1 residue3: F4O 
 
  TEMPLATE::   ATOM_MAP: 2 atom_name: SG CB CA 
  TEMPLATE::   ATOM_MAP: 2 residue1: C 
 
  CONSTRAINT:: distanceAB:    2.40   0.30 100.00  1        2 
  CONSTRAINT::    angle_A:  106.00   6.00 100.00  360.00   1 
  CONSTRAINT::    angle_B:  170.00  10.00  50.00  360.00   2 
    
  ALGORITHM_INFO:: match 
    CHI_STRATEGY:: CHI 1 EX_FOUR_HALF_STEP_STDDEVS 
 IGNORE_UPSTREAM_PROTON_CHI 
 SECONDARY_MATCH: DOWNSTREAM 
  ALGORITHM_INFO::END 
   
CST::END 
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Code 4.3. Rosetta ligand parameter file for [Fe4S4] cluster. 
NAME F4O 
IO_STRING F4O Z 
TYPE LIGAND 
AA UNK 
ATOM FE1  Fe3p  X   1.58 
ATOM  S2  S     X   -1.58 
ATOM FE4  Fe3p  X   1.58 
ATOM FE2  Fe3p  X   1.58 
ATOM  S4  S     X   -1.58 
ATOM FE3  Fe3p  X   1.58 
ATOM  S3  S     X   -1.58 
ATOM  S1  S     X   -1.58 
BOND  S2  FE4  
BOND  S2  FE1  
BOND  S2  FE2  
BOND FE4  FE1  
BOND FE4  FE2  
BOND FE4   S3  
BOND FE4   S4  
BOND FE4  FE3  
BOND FE1  FE2  
BOND FE1   S3  
BOND FE1  FE3  
BOND FE1   S1  
BOND FE2   S4  
BOND FE2  FE3  
BOND FE2   S1  
BOND  S3  FE3  
BOND  S4  FE3  
BOND FE3   S1  
NBR_ATOM FE1  
NBR_RADIUS 3.967548 
ICOOR_INTERNAL   FE1     0.000000    0.000000    0.000000  FE1    S2   FE4  
ICOOR_INTERNAL    S2     0.000000  180.000000    2.335732  FE1    S2   FE4  
ICOOR_INTERNAL   FE4     0.000000  107.421730    2.343594   S2   FE1   FE4  
ICOOR_INTERNAL   FE2   -76.847206  126.420234    2.769515  FE4    S2   FE1  
ICOOR_INTERNAL    S4  -159.917952  126.420234    2.343594  FE2   FE4    S2  
ICOOR_INTERNAL   FE3   -76.847206  107.421730    2.335732   S4   FE2   FE4  
ICOOR_INTERNAL    S3    93.812278   75.246352    2.335732  FE3    S4   FE2  
ICOOR_INTERNAL    S1  -110.438908   74.935730    2.343594  FE3    S4    S3 
 
Code 4.4. Flags file for running attempt 1 
-s ../Cys-heme_CcP_frame1003_res1Met.pdb 
-match:lig_name F4O 
-match:scaffold_active_site_residues_for_geomcsts ../Cys-heme_CcP_attempt1.pos 
-match:geometric_constraint_file ../Cys-heme_CcP_attempt1.cst 
-extra_res_fa ../4FE4S.params 
-use_input_sc 
-match:output_format CloudPDB 
-match_grouper SameSequenceAndDSPositionGrouper  
#-output_matchres_only true 
-enumerate_ligand_rotamers 
-only_enumerate_non_match_redundant_ligand_rotamers 
-packing:ex1 
-packing:ex2 
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Code 4.5. Positions file for attempt 1 (for attempt to change N_CST to 3 and remove line 4) 
N_CST 4 
1: 175 
2: 172 180 191 202 230 232 235 238 
3: 172 180 191 202 230 232 235 238 
4: 172 180 191 202 230 232 235 238 
 
4.4.2. Molecular dynamics simulations 
Molecular dynamics simulations were carried out in NAMD.43 Mutations were made using 
PSFGEN. Standard CHARMM44 topology and parameter files were used, with the added parameters 
derived from Chang and Kim38 in the next section. The water box size was at least 3 times the size 
of the protein in each direction. Simulation was carried out with 5000 steps of minimization, 
followed by several nan0seconds of dynamics. 
4.4.3. NAMD topology and parameter files 
Code 4.6. Topology file for Fe4S4 cluster 
! [4Fe-4S]2+ resname F4O 
MASS  5 FEJO    55.84700 ! 
MASS  6 SJO     32.06600 ! 
 
!!! Oxidized [4Fe4S] cluster segments HYDA, HYDB, HYDC 
RESI F4O         0.54050 ! 
 
GROUP 
 ATOM  FE1  FEJO  1.10417 
 ATOM  FE2  FEJO  1.10417 
 ATOM  FE3  FEJO  1.10417 
 ATOM  FE4  FEJO  1.10417 
 ATOM  S1   SJO  -0.96905 
 ATOM  S2   SJO  -0.96905 
 ATOM  S3   SJO  -0.96905 
 ATOM  S4   SJO  -0.96905 
 BOND  FE1  S1         FE1  S2         FE1  S3         FE2  S1 
 BOND  FE2  S2         FE2  S4         FE3  S2         FE3  S3 
 BOND  FE3  S4         FE4  S1         FE4  S3         FE4  S4 
 BOND  FE1 FE2         FE1 FE3         FE1 FE4         FE2 FE3 
 BOND  FE2 FE4         FE3 FE4 
 ANGL    FE1     S3      FE4     FE1     S3      FE3     S4      FE2     FE1 
 ANGL    FE1     S2      FE3     FE1     S2      FE2     FE1     S1      FE4 
 ANGL    FE1     S1      FE2     FE1     FE4     FE3     FE1     FE4     FE2 
 ANGL    FE1     FE3     FE4     FE1     FE3     FE2     FE1     FE2     FE4 
 ANGL    FE1     FE2     FE3     FE2     S4      FE4     FE2     S4      FE3 
 ANGL    FE2     S2      FE3     FE2     S1      FE4     FE2     FE4     FE3 
 ANGL    FE2     FE3     FE4     FE2     FE1     FE4     FE2     FE1     FE3 
 ANGL    FE3     S4      FE4     FE3     S3      FE4     FE3     FE2     FE4 
 ANGL    FE3     FE1     FE4     S1      FE4     FE3     S1      FE4     FE2 
 ANGL    S1      FE4     FE1     S1      FE4     S4      S1      FE4     S3 
 ANGL    S1      FE2     FE4     S1      FE2     FE3     S1      FE2     FE1 
 ANGL    S1      FE2     S4      S1      FE2     S2      S1      FE1     FE4 
 ANGL    S1      FE1     FE3     S1      FE1     FE2     S1      FE1     S3 
 ANGL    S1      FE1     S2      S2      FE3     FE4     S2      FE3     FE2 
 ANGL    S2      FE3     FE1     S2      FE3     S4      S2      FE3     S3 
 ANGL    S2      FE2     FE4     S2      FE2     FE3     S2      FE2     FE1 
 ANGL    S2      FE2     S4      S2      FE1     FE4     S2      FE1     FE3 
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 ANGL    S2      FE1     FE2     S2      FE1     S3      S3      FE4     FE3 
 ANGL    S3      FE4     FE2     S3      FE4     FE1     S3      FE4     S4 
 ANGL    S3      FE3     FE4     S3      FE3     FE2     S3      FE3     FE1 
 ANGL    S3      FE3     S4      S3      FE1     FE4     S3      FE1     FE3 
 ANGL    S3      FE1     FE2     S4      FE4     FE3     S4      FE4     FE2 
 ANGL    S4      FE4     FE1     S4      FE3     FE4     S4      FE3     FE2 
 ANGL    S4      FE3     FE1     S4      FE2     FE4     S4      FE2     FE3 
 DIHE    FE1     S3      FE3     FE2     FE1     S3      FE3     FE4 
 DIHE    FE1     S3      FE4     FE2     FE1     S3      FE4     FE3 
 DIHE    FE1     S2      FE2     FE3     FE1     S2      FE2     FE4 
 DIHE    FE1     S2      FE3     FE2     FE1     S2      FE3     FE4 
 DIHE    FE1     S1      FE2     FE3     FE1     S1      FE2     FE4 
 DIHE    FE1     S1      FE4     FE2     FE1     FE2     FE4     FE3 
 DIHE    FE1     S1      FE4     FE3     FE1     FE4     S1      FE2 
 DIHE    FE1     FE4     S3      FE3     FE1     FE4     S4      FE2 
 DIHE    FE1     FE4     S4      FE3     FE1     FE4     FE2     S1 
 DIHE    FE1     FE4     FE2     S2      FE1     FE4     FE2     S4 
 DIHE    FE1     FE4     FE2     FE3     FE1     FE4     FE3     S2 
 DIHE    FE1     FE4     FE3     S3      FE1     FE4     FE3     S4 
 DIHE    FE1     FE4     FE3     FE2     FE1     FE3     S2      FE2 
 DIHE    FE1     FE3     S3      FE4     FE1     FE3     S4      FE2 
 DIHE    FE1     FE3     S4      FE4     FE1     FE3     FE2     S1 
 DIHE    FE1     FE3     FE2     S2      FE1     FE3     FE2     S4 
 DIHE    FE1     FE3     FE2     FE4     FE1     FE3     FE4     S1 
 DIHE    FE1     FE3     FE4     S3      FE1     FE3     FE4     S4 
 DIHE    FE1     FE3     FE4     FE2     FE1     FE2     S1      FE4 
 DIHE    FE1     FE2     S2      FE3     FE1     FE2     S4      FE3 
 DIHE    FE1     FE2     S4      FE4     FE1     FE2     FE3     S2 
 DIHE    FE1     FE2     FE3     S3      FE1     FE2     FE3     S4 
 DIHE    FE1     FE2     FE3     FE4     FE1     FE2     FE4     S1 
 DIHE    FE1     FE2     FE4     S3      FE1     FE2     FE4     S4 
 DIHE    FE2     S4      FE3     FE4     FE2     S4      FE4     FE3 
 DIHE    FE2     S2      FE1     FE3     FE2     S2      FE1     FE4 
 DIHE    FE2     S2      FE3     FE4     FE2     FE1     FE4     FE3 
 DIHE    FE2     S1      FE1     FE3     FE2     S1      FE1     FE4 
 DIHE    FE2     S1      FE4     FE3     FE2     FE4     S3      FE3 
 DIHE    FE2     FE4     S4      FE3     FE2     FE4     FE1     S1 
 DIHE    FE2     FE4     FE1     S2      FE2     FE4     FE1     S3 
 DIHE    FE2     FE4     FE1     FE3     FE2     FE4     FE3     S2 
 DIHE    FE2     FE4     FE3     S3      FE2     FE4     FE3     S4 
 DIHE    FE2     FE3     S3      FE4     FE2     FE3     S4      FE4 
 DIHE    FE2     FE3     FE1     S1      FE2     FE3     FE1     S2 
 DIHE    FE2     FE3     FE1     S3      FE2     FE3     FE1     FE4 
 DIHE    FE2     FE3     FE4     S1      FE2     FE3     FE4     S3 
 DIHE    FE2     FE3     FE4     S4      FE2     FE1     S1      FE4 
 DIHE    FE2     FE1     S2      FE3     FE2     FE1     S3      FE3 
 DIHE    FE2     FE1     S3      FE4     FE2     FE1     FE3     S2 
 DIHE    FE2     FE1     FE3     S3      FE2     FE1     FE3     S4 
 DIHE    FE2     FE1     FE3     FE4     FE2     FE1     FE4     S1 
 DIHE    FE2     FE1     FE4     S3      FE2     FE1     FE4     S4 
 DIHE    FE3     S4      FE2     FE4     FE3     S3      FE1     FE4 
 DIHE    FE3     S2      FE1     FE4 
 DIHE    FE3     S2      FE2     FE4     FE3     FE4     FE1     S1 
 DIHE    FE3     FE4     FE1     S2      FE3     FE4     FE1     S3 
 DIHE    FE3     FE4     FE2     S1      FE3     FE4     FE2     S2 
 DIHE    FE3     FE4     FE2     S4      FE3     FE2     S1      FE4 
 DIHE    FE3     FE2     S4      FE4     FE3     FE2     FE1     S1 
 DIHE    FE3     FE2     FE1     S2      FE3     FE2     FE1     S3 
 DIHE    FE3     FE2     FE1     FE4     FE3     FE2     FE4     S1 
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 DIHE    FE3     FE2     FE4     S3      FE3     FE2     FE4     S4 
 DIHE    FE3     FE1     S1      FE4     FE3     FE1     S3      FE4 
 DIHE    FE3     FE1     FE2     S1      FE3     FE1     FE2     S2 
 DIHE    FE3     FE1     FE2     S4      FE3     FE1     FE2     FE4 
 DIHE    FE3     FE1     FE4     S1      FE3     FE1     FE4     S3 
 DIHE    FE3     FE1     FE4     S4      FE4     FE3     FE1     S1 
 DIHE    FE4     FE3     FE1     S2      FE4     FE3     FE1     S3 
 DIHE    FE4     FE3     FE2     S1      FE4     FE3     FE2     S2 
 DIHE    FE4     FE3     FE2     S4      FE4     FE2     FE1     S1 
 DIHE    FE4     FE2     FE1     S2      FE4     FE2     FE1     S3 
 DIHE    FE4     FE2     FE3     S2      FE4     FE2     FE3     S3 
 DIHE    FE4     FE2     FE3     S4      FE4     FE1     FE2     S1 
 DIHE    FE4     FE1     FE2     S2      FE4     FE1     FE2     S4 
 DIHE    FE4     FE1     FE3     S2      FE4     FE1     FE3     S3 
 DIHE    FE4     FE1     FE3     S4      S1      FE4     FE1     S2 
 DIHE    S1      FE4     FE1     S3      S1      FE4     FE2     S2 
 DIHE    S1      FE4     FE2     S4      S1      FE4     FE3     S2 
 DIHE    S1      FE4     FE3     S3      S1      FE4     FE3     S4 
 DIHE    S1      FE2     FE1     S2      S1      FE2     FE1     S3 
 DIHE    S1      FE2     FE3     S2      S1      FE2     FE3     S3 
 DIHE    S1      FE2     FE3     S4      S1      FE2     FE4     S3 
 DIHE    S1      FE2     FE4     S4      S1      FE1     FE2     S2 
 DIHE    S1      FE1     FE2     S4      S1      FE1     FE3     S2 
 DIHE    S1      FE1     FE3     S3      S1      FE1     FE3     S4 
 DIHE    S1      FE1     FE4     S3      S1      FE1     FE4     S4 
 DIHE    S2      FE3     FE1     S3      S2      FE3     FE2     S4 
 DIHE    S2      FE3     FE4     S3      S2      FE3     FE4     S4 
 DIHE    S2      FE2     FE1     S3      S2      FE2     FE3     S3 
 DIHE    S2      FE2     FE3     S4      S2      FE2     FE4     S3 
 DIHE    S2      FE2     FE4     S4      S2      FE1     FE2     S4 
 DIHE    S2      FE1     FE3     S3      S2      FE1     FE3     S4 
 DIHE    S2      FE1     FE4     S3      S2      FE1     FE4     S4 
 DIHE    S3      FE4     FE2     S4      S3      FE4     FE3     S4 
 DIHE    S3      FE3     FE2     S4      S3      FE3     FE4     S4 
 DIHE    S3      FE1     FE2     S4      S3      FE1     FE3     S4 
 DIHE    S3      FE1     FE4     S4 
 
PRES F4-1O       -0.78829 ! patch for CYS to FE1 of oxidized [4Fe4S] (1-F4O 2-
CYS). 
ATOM 2N    NH1    -0.47 
ATOM 2HN   H       0.31 
ATOM 2CA   CT1     0.07 
ATOM 2HA   HB      0.09 
ATOM 2CB   CT2    -0.898872 
ATOM 2HB1  HA      0.342857 
ATOM 2HB2  HA      0.342857 
ATOM 2SG   S      -0.575132 
DELETE ATOM 2HG1 
BOND 1FE1 2SG 
ANGL 1FE2 1FE1 2SG 
ANGL 1FE3 1FE1 2SG 
ANGL 1FE4 1FE1 2SG 
ANGL 1S1 1FE1 2SG 
ANGL 1S2 1FE1 2SG 
ANGL 1S3 1FE1 2SG 
ANGL 1FE1 2SG 2CB 
DIHE 1FE1 2SG 2CB 2HB1 
DIHE 1FE1 2SG 2CB 2HB2 
DIHE 1FE2 1FE1 2SG 2CB 
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DIHE 1FE2 1FE3 1FE1 2SG 
DIHE 1FE2 1FE4 1FE1 2SG 
DIHE 1FE2 1S1  1FE1 2SG 
DIHE 1FE2 1S2  1FE1 2SG 
DIHE 1FE3 1FE1 2SG 2CB 
DIHE 1FE3 1FE2 1FE1 2SG 
DIHE 1FE3 1FE4 1FE1 2SG 
DIHE 1FE3 1S2  1FE1 2SG 
DIHE 1FE3 1S3  1FE1 2SG 
DIHE 1FE4 1FE1 2SG 2CB 
DIHE 1FE4 1FE2 1FE1 2SG 
DIHE 1FE4 1FE3 1FE1 2SG 
DIHE 1FE4 1S1  1FE1 2SG 
DIHE 1FE4 1S3  1FE1 2SG 
DIHE 1S1 1FE2 1FE1 2SG 
DIHE 1S1 1FE4 1FE1 2SG 
DIHE 1S1 1FE1 2SG 2CB 
DIHE 1S2 1FE2 1FE1 2SG 
DIHE 1S2 1FE3 1FE1 2SG 
DIHE 1S2 1FE1 2SG 2CB 
DIHE 1S3 1FE3 1FE1 2SG 
DIHE 1S3 1FE4 1FE1 2SG 
DIHE 1S3 1FE1 2SG 2CB 
DIHE 1S4 1FE2 1FE1 2SG 
DIHE 1S4 1FE3 1FE1 2SG 
DIHE 1S4 1FE4 1FE1 2SG 
 
PRES F4-2O       -0.78829 ! patch for CYS to FE2 of oxidized [4Fe4S] (1-F4O 2-
CYS). 
ATOM 2N    NH1    -0.47 
ATOM 2HN   H       0.31 
ATOM 2CA   CT1     0.07 
ATOM 2HA   HB      0.09 
ATOM 2CB   CT2    -0.898872 
ATOM 2HB1  HA      0.342857 
ATOM 2HB2  HA      0.342857 
ATOM 2SG   S      -0.575132 
DELETE ATOM 2HG1 
BOND 1FE2 2SG 
ANGL 1FE1 1FE2 2SG 
ANGL 1FE3 1FE2 2SG 
ANGL 1FE4 1FE2 2SG 
ANGL 1S1 1FE2 2SG 
ANGL 1S2 1FE2 2SG 
ANGL 1S4 1FE2 2SG 
ANGL 1FE2 2SG 2CB 
DIHE 1FE1 1FE2 2SG 2CB 
DIHE 1FE1 1FE3 1FE2 2SG 
DIHE 1FE1 1FE4 1FE2 2SG 
DIHE 1FE1 1S1 1FE2 2SG 
DIHE 1FE1 1S2 1FE2 2SG 
DIHE 1FE2 2SG 2CB 2HB1 
DIHE 1FE2 2SG 2CB 2HB2 
DIHE 1FE3 1FE1 1FE2 2SG 
DIHE 1FE3 1FE2 2SG 2CB    
DIHE 1FE3 1FE4 1FE2 2SG 
DIHE 1FE3 1S2 1FE2 2SG 
DIHE 1FE3 1S4 1FE2 2SG    
DIHE 1FE4 1FE1 1FE2 2SG    
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DIHE 1FE4 1FE2 2SG 2CB 
DIHE 1FE4 1FE3 1FE2 2SG    
DIHE 1FE4 1S1 1FE2 2SG    
DIHE 1FE4 1S4 1FE2 2SG 
DIHE 1S1 1FE4 1FE2 2SG 
DIHE 1S1 1FE1 1FE2 2SG    
DIHE 1S1 1FE2 2SG 2CB 
DIHE 1S2 1FE2 2SG 2CB    
DIHE 1S2 1FE3 1FE2 2SG 
DIHE 1S2 1FE1 1FE2 2SG    
DIHE 1S3 1FE4 1FE2 2SG    
DIHE 1S3 1FE3 1FE2 2SG 
DIHE 1S3 1FE1 1FE2 2SG    
DIHE 1S4 1FE3 1FE2 2SG 
DIHE 1S4 1FE2 2SG 2CB 
DIHE 1S4 1FE4 1FE2 2SG 
 
PRES F4-3O       -0.78829 ! patch for CYS to FE3 of oxidized [4Fe4S] (1-F4O 2-
CYS). 
ATOM 2N    NH1    -0.47 
ATOM 2HN   H       0.31 
ATOM 2CA   CT1     0.07 
ATOM 2HA   HB      0.09 
ATOM 2CB   CT2    -0.898872 
ATOM 2HB1  HA      0.342857 
ATOM 2HB2  HA      0.342857 
ATOM 2SG   S      -0.575132 
DELETE ATOM 2HG1 
BOND 1FE3 2SG 
ANGL 1FE1 1FE3 2SG 
ANGL 1FE2 1FE3 2SG 
ANGL 1FE4 1FE3 2SG 
ANGL 1S2 1FE3 2SG 
ANGL 1S3 1FE3 2SG 
ANGL 1S4 1FE3 2SG 
ANGL 1FE3 2SG 2CB 
DIHE 1FE1 1FE2 1FE3 2SG 
DIHE 1FE1 1FE4 1FE3 2SG 
DIHE 1FE1 1FE3 2SG 2CB 
DIHE 1FE1 1S2 1FE3 2SG 
DIHE 1FE1 1S3 1FE3 2SG 
DIHE 1FE2 1FE1 1FE3 2SG 
DIHE 1FE2 1FE3 2SG 2CB 
DIHE 1FE2 1FE4 1FE3 2SG 
DIHE 1FE2 1S2 1FE3 2SG 
DIHE 1FE2 1S4 1FE3 2SG 
DIHE 1FE3 2SG 2CB 2HB1 
DIHE 1FE3 2SG 2CB 2HB2 
DIHE 1FE4 1FE1 1FE3 2SG 
DIHE 1FE4 1FE2 1FE3 2SG 
DIHE 1FE4 1FE3 2SG 2CB 
DIHE 1FE4 1S3 1FE3 2SG 
DIHE 1FE4 1S4 1FE3 2SG 
DIHE 1S1 1FE1 1FE3 2SG 
DIHE 1S1 1FE2 1FE3 2SG 
DIHE 1S1 1FE4 1FE3 2SG 
DIHE 1S2 1FE1 1FE3 2SG 
DIHE 1S2 1FE2 1FE3 2SG 
DIHE 1S2 1FE3 2SG 2CB 
Code 4.6. (cont.) 
99 
 
DIHE 1S3 1FE1 1FE3 2SG 
DIHE 1S3 1FE3 2SG 2CB 
DIHE 1S3 1FE4 1FE3 2SG 
DIHE 1S4 1FE2 1FE3 2SG 
DIHE 1S4 1FE3 2SG 2CB 
DIHE 1S4 1FE4 1FE3 2SG 
 
PRES F4-4O       -0.635126 ! patch for CYS to FE4 of oxidized [4Fe4S] (1-F4O 2-
CYS). 
ATOM 2N    NH1    -0.47 
ATOM 2HN   H       0.31 
ATOM 2CA   CT1     0.07 
ATOM 2HA   HB      0.09 
ATOM 2CB   CT2    -0.82229 
ATOM 2HB1  HA      0.342857 
ATOM 2HB2  HA      0.342857 
ATOM 2SG   S      -0.49855 
DELETE ATOM 2HG1 
BOND 1FE4 2SG 
ANGL 1FE1 1FE4 2SG 
ANGL 1FE2 1FE4 2SG 
ANGL 1FE3 1FE4 2SG 
ANGL 1S1 1FE4 2SG 
ANGL 1S3 1FE4 2SG 
ANGL 1S4 1FE4 2SG 
ANGL 1FE4 2SG 2CB 
DIHE 1FE1 1FE2 1FE4 2SG 
DIHE 1FE1 1FE3 1FE4 2SG 
DIHE 1FE1 1FE4 2SG 2CB 
DIHE 1FE1 1S1 1FE4 2SG 
DIHE 1FE1 1S3 1FE4 2SG 
DIHE 1FE2 1FE1 1FE4 2SG 
DIHE 1FE2 1FE3 1FE4 2SG 
DIHE 1FE2 1FE4 2SG 2CB 
DIHE 1FE2 1S1 1FE4 2SG 
DIHE 1FE2 1S4 1FE4 2SG 
DIHE 1FE3 1FE1 1FE4 2SG 
DIHE 1FE3 1FE2 1FE4 2SG 
DIHE 1FE3 1FE4 2SG 2CB 
DIHE 1FE3 1S3 1FE4 2SG 
DIHE 1FE3 1S4 1FE4 2SG 
DIHE 1FE4 2SG 2CB 2HB1 
DIHE 1FE4 2SG 2CB 2HB2 
DIHE 1S1 1FE1 1FE4 2SG 
DIHE 1S1 1FE2 1FE4 2SG 
DIHE 1S1 1FE4 2SG 2CB 
DIHE 1S2 1FE1 1FE4 2SG 
DIHE 1S2 1FE2 1FE4 2SG 
DIHE 1S2 1FE3 1FE4 2SG 
DIHE 1S3 1FE1 1FE4 2SG 
DIHE 1S3 1FE3 1FE4 2SG 
DIHE 1S3 1FE4 2SG 2CB 
DIHE 1S4 1FE2 1FE4 2SG 
DIHE 1S4 1FE3 1FE4 2SG 
DIHE 1S4 1FE4 2SG 2CB 
 
PRES HCB               ! patch to bond bridging CYS to FE1 of H-Cluster (1-HCR 
2-CYS). Must apply this after F4-X-type patch! 
BOND 1FE1 2SG 
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ANGLE  2SG  1FE1  1S1    2SG  1FE1  1S2   1FE2  1FE1  2SG 
ANGLE  1FE1  2SG  2CB    2SG  1FE1  1C4   2SG   1FE1  1C3 
IMPR   2SG  1S1  1FE1  1C5    1S1  1FE1  2SG  1C3 
 
PRES PHCF         0.00 ! Patch for HEME to thiolate (CYS-(F4O)) link 
                       ! Patch residues must be 1-CYS, and 2-HEME. 
                       ! do NOT use AUTOgenerate ANGLes DIHEdrals after this 
patch 
        ! apply after F4-X type patch! 
 
DELETE ANGLE 2NA 2FE 2NC  2NB 2FE 2ND 
BOND  1SG 2FE 
ANGLE 1CB 1SG  2FE  1CB 1SG  2FE   
ANGLE 1SG  2FE 2NA  1SG  2FE 2NB 1SG  2FE  2NC  1SG  2FE  2ND 
IC 1CB 1SG  2FE  2NA   0.0000  0.0000    0.0000  0.0000  0.0000 
IC 1CB 1SG  2FE  2NB   0.0000  0.0000    0.0000  0.0000  0.0000 
IC 1CB 1SG  2FE  2NC   0.0000  0.0000    0.0000  0.0000  0.0000 
IC 1CB 1SG  2FE  2ND   0.0000  0.0000    0.0000  0.0000  0.0000 
 
END 
 
Code 4.7. Additional force-field parameters. 
 
!Heme to Sulfate (PSUL) link 
S    FE    250.0       2.3200 !force constant a guess 
           !equilbrium bond length optimized to reproduce  
           !CSD survey values of 
           !2.341pm0.01 (mean, standard error) 
           !adm jr., 7/01 
SS   FE    250.0       2.3200 !force constant a guess 
           !equilbrium bond length optimized to reproduce  
           !CSD survey values of 
           !2.341pm0.01 (mean, standard error) 
           !adm jr., 7/01 
! 
!!! F4O bonds !!! 
FEJO  FEJO    38.18   2.628 
FEJO  SJO    115.84   2.175 
FEJO  S      178.70   2.251 
! 
 
!Heme to Sulfate (PSUL) link 
CT2  S    FE    50.0      100.6    !force constant a guess 
                !equilibrium angle optimized to reproduce 
                !CSD survey values 
                !107.5pm0.6 (mean, standard error) 
                !adm jr., 7/01 
S    FE   NPH   100.0       90.0    !force constant a guess 
                !adm jr., 7/01 
! 
CS   SS   FE    50.0      100.6    !force constant a guess 
                !equilibrium angle optimized to reproduce 
                !CSD survey values 
                !107.5pm0.6 (mean, standard error) 
                !adm jr., 7/01 
SS   FE   NPH   100.0       90.0    !force constant a guess 
                !adm jr., 7/01 
! 
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!!! F4O angles 
FEJO  FEJO  FEJO     0.713    60.00 
SJO   FEJO   SJO     4.313   103.69 
FEJO   SJO  FEJO     2.725    74.35 
FEJO  FEJO   SJO     2.290   100.49 
S     FEJO   SJO     2.449   114.73 
FEJO  FEJO   S       0.850   144.61 
FEJO  S      CT2    74.621   106.29 
FEJO  S      FEM1  500.000   118.00 
FEJO  S      FEL1  500.000   118.00 
! 
 
!Heme to Sulfate (PSUL) link 
X    FE   S    X        0.0000  4     0.00 ! guess 
                !adm jr., 7/01 
X    FE   SS   X        0.0000  4     0.00 ! guess 
                !adm jr., 7/01 
CT1  CT2  S    FE       0.2000  3     0.00 ! guess 
                !from methanethiol, HS S CT3 HA 
                !adm jr., 7/01 
X    CS   SS   X        0.2000  3     0.00 ! guess 
                !from methanethiol, HS S CT3 HA 
                !adm jr., 7/01 
 
!!! F4O dihedrals !!! 
FEJO  S     CT2    HA    14.03    3     0.0 
FEJO  FEJO  S      CT2    1.04    3   180.0 
CT2   S     FEJO   SJO    1.17    3     0.0 
S     FEJO  FEJO   FEJO   0.48    5   180.0 
S     FEJO  FEJO   SJO    1.44    0   180.0 
FEJO  FEJO  FEJO   SJO    1.16   10   180.0 
SJO   FEJO  FEJO   SJO    2.16    0     0.0 
S     FEJO  SJO    FEJO   0.64    5   180.0 
FEJO  FEJO  SJO    FEJO   0.72   10   180.0 
FEJO  FEJO  FEJO  FEJO    0.36    5   180.0 
FEJO  SJO   FEJO   SJO    0       0     0 
! 
 
 
SJO    0.000000  -0.380000     1.975 
FEJO   0.000000  -0.011500     1.442 
! 
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CHAPTER 5 
TOWARDS CRYSTAL STRUCTURE DETERMINATION OF AN 8-17 DNAZYME 
5.1. Background 
DNA is well known as the long term storage medium of cellular functions. The genes 
encoded in DNA store the information needed to synthesize proteins which carry out numerous 
complex chemical and regulatory functions. Translation of DNA code to protein is mediated by 
RNA.1 However, in addition to functioning as messengers between DNA and protein synthesis, RNA 
has been found to perform a number of important functions of its own.2,3 Splicing of messenger 
RNA plays an important role in proper protein synthesis.2,4 RNAs constitute a substantial fraction 
of the ribosome3 and are responsible for catalyzing peptide bond formation during protein 
synthesis. In plants and bacteria, RNA sequences known as riboswitches which control gene 
expression by rapidly responding to metabolite binding.5-8 These natural examples of functional 
nucleic acids set the stage for discovery of non-natural counterparts. 
The in vitro isolation of functional nucleic acids began in 1990 with the development of a 
process known as Systematic Evolution of Ligand by EXponential enrichment (SELEX).9,10 This 
resulted in isolation of ligand binding RNA aptamers, and novel ribozymes.9-11 Concurrently, the 
strategy was also applied to DNA and resulted in the first DNA aptamers for similar targets.12,13 
Shortly thereafter, a DNA sequence capable of phosphodiester bond cleavage was isolated,14 and 
the term DNAzyme was coined to describe the class of catalytically active DNA. Since then, 
numerous DNAzymes have been isolated that perform myriad functions under various specific 
conditions.15-31 
 
Figure 5.1.  The secondary structure and catalytic function of an 8-17 DNAzyme. 
The best characterized DNAzyme is known as the 8-17 DNAzyme,32 whose secondary 
structure is shown in Figure 5.1. This DNAzyme catalyzes phosphodiester bond cleavage of a 
ribonucleobase in the presence of divalent metal ions, such as Mg2+, Pb2+, Zn2+, and Mn2+. It has 
been the subject of countless biochemical and biophysical studies, which have shown light on its 
mechanism.33-43 Its structure has been probed by numerous techniques, including 
crosslinking,38,39,42 FRET,36,40,44,45 and circular dichroism (CD).40 Although these studies have 
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confirmed the secondary structure and provided insights into conformational changes that occur 
upon interaction with metal, no atomic resolution structure of 8-17 DNAzyme, in its active 
configuration has been reported. Such a structure would be invaluable in opening a new frontier in 
the rational engineering of DNAzaymes. Recently, the structure RNA-ligating DNAzyme was 
reported, and is the first and only active DNAzyme structure known.46 
5.2. Previous attempts and challenges of DNAzyme crystallization 
The only known crystal structure of a DNAzyme sequence is of the so-called 12-23 DNAzyme 
sequence.47 Obtained in 1999 by Joyce and coworkers, the structure reveals the enzyme and 
substrate strands forming a 2:2 enzyme-substrate complex and adopting a four-way junction 
structure, inconsistent with its known active configuration. Given the high value of an atomic 
resolution structure of a DNAzyme, it is all but certain that work to obtain such structures 
continues to be pursued, though no further progress has been reported. 
Nucleic acids pose two major unique crystallographic challenges: (1) uniform negative 
charge of the backbone results in weak, non-specific crystal packing, resulting in disordered 
lattices;48 (2) the structures adopted by nucleic acids are highly heterogeneous in solution.49 Two 
methods of overcoming these problems are protein co-crystallization and so called “helix-
engineering”. Helix engineering involves incorporation of a known crystallizable sequence into a 
non-essential part of the construct to facilitate crystallization. Co-crystallization involves 
incorporation of a protein binding sequence or motif onto the DNA to allow the protein to drive 
crystallization of the DNAzyme. Prior efforts in the Lu lab utilizing these approaches and others to 
attempt to obtain diffraction quality crystals of active 8-17 DNAzyme are reported briefly. More 
detailed information about these attempts can be found in the thesis of Dr. Tian Lan (2012). 
Co-crystallization of the 8-17 DNAzyme sequence was attempted with two constructs: (1) 
biotinylated DNA co-crystallized with avidin and (2) lysozyme co-crystallized with a DNAzyme 
bearing the lysozyme aptamer sequence. The lysozyme co-crystallization did not yield crystals, 
likely due to the aptamer interfering with lysozyme packing. Co-crystallization with avidin did in 
fact yield diffraction quality crystals. However, only biotin could be resolved, with the remainder 
of the DNAzyme too disordered. 
Helix-engineering was carried out by introducing a commonly crystallized double-stranded 
DNA sequence known as the Drew-Dickerson dodecamer (DDD) sequence50-63 in the non-catalytic 
double-stranded arm of the 8-17 DNAzyme. Crystallization of many different constructs with 
various overhanging nucleotides were attempted under a variety of crystallization screening 
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conditions. Finally, crystals of two constructs, E-3’T/S-5’A and E/S-3’T, were obtained under a small 
range of crystallization conditions (see Materials and methods). However, after several attempts to 
obtain diffraction data from these crystals, the highest resolution achieved was 5 Å, not sufficient 
to solve the structure.  
5.3. Crystal preparation and diffraction screening 
As stated above, despite successes in crystallizing the 8-17 DNAzyme sequence, no 
substantial diffraction could be obtained. This could be due to two main reasons: (1) the quality of 
crystals themselves is too low to obtain significant diffraction, or (2) the crystal quality deteriorates 
during crystal handling in preparation for diffraction. In order to determine which is true in this 
case, I proposed to screen the crystals for diffraction at room temperature. In this way, the crystal 
could be maintained in the exact same solution and atmosphere under which it grew, minimizing 
chances of deterioration. 
Crystal trays of 8-17 DNAzyme E/S-3’A were carefully transported to the APS on ice. A single 
~50 μm diameter crystal (Figure 5.2) was harvested using the mitogen RT sleeve system, with the 
sleeve filled with motherliquor from the drop. This crystal was placed on LS-CAT beamline 21-ID-
F. Screening revealed very good diffraction to ~3.0 Å resolution (Figure 5.3). Indexing of the images 
revealed a trigonal or hexagonal unit cell with dimensions 64 x 64 x 66 Å. This result confirmed 
that the quality of the crystals as grown is sufficient for modest diffraction data collection, and 
suggested that crystal preparation for cryogenic diffraction was responsible for deterioration. The 
most likely explanation is that the cryoprotectant conditions were incompatible with the crystals. 
 
Figure 5.2. Example drop of 8-17 DNAzyme E/S-3’A crystals. 
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Figure 5.3. Images of diffraction of DNAzyme crystal at room temperature. 
5.4. Optimization of cryoprotection conditions 
Previously, crystals were cryoprotected by mixing PEG 400 or glycerol, up to 30% w/v final 
concentration, with the well buffer against which the DNA was crystallized. Both the addition of 
these additives and the dilution of the precipitant concentration by its addition may be responsible 
for deterioration of the crystal. In order to stabilize the crystal during soaking, the concentration of 
precipitant was first increased, by soaking the crystal in 1.1 M lithium sulfate. Subsequently, the 
crystal was soaked in freshly prepared solutions containing 1.1 M lithium sulfate and increasing 
concentrations of glycerol, up to 20%. No visible deterioration was observed, and the cryocooled 
crystal scattered X-rays to 2.7 Å resolution. Later, sodium gluconate was also successfully used as a 
cryoprotectant, also using increased precipitant concentration. 
5.5. Preparation of heavy-atom derivatives 
One method of solving novel crystal structures involves preparation of one or more heavy-
atom derivatives of the crystal (see Section 5.7.2). The native crystal was grown in the presence of 
lead, but no lead signal could be detected in the crystal by X-ray fluorescence. This is likely due to 
precipitation of lead in the presence of high sulfate concentration. Likewise, a crystal grown in Sr2+ 
did not yield anomalous absorption signal that could be used for structure solving. Attempts to 
soak the crystal with Zn2+ and Mn2+ did not yield anomalous signal. Attempts to grow crystals 
containing Br-dU and Se-dA have not produced diffractable crystals. Finally, soaking with 1 mM 
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TaBr cluster produced measurable anomalous diffraction in the crystallographic data, which might 
be usable for structure solving. 
5.6. Data collection 
Data collection was carried out at APS on NECAT beamlines 24-ID-C and 24-ID-E. Three 
datasets were collected: (1) native DNAzyme crystal grown in presence of Pb but no other heavy 
atoms added; (2) DNAzyme crystals soaked with TaBr clusters; (3) DNAzyme crystals grown in 
presence of Sr. The data collection statistics are given bellow. 
Table 5.1.  Data collection statistics for DNAzyme crystal datasets 
 DNAzyme (native) DNAzyme (+TaBr) DNAzyme (Sr)* 
Data Collection    
Source APS 24-ID-C APS 24-ID-E APS 24-ID-C 
Date 2013-03-17 2015-02-13  
Detector DETRIS Pilatus 6M ADSC HF-4M DETRIS Pilatus 6M 
Wavelength (Å) 0.9497 0.9791  
    
Data Reduction    
Software === RAPD pipeline at NECAT === 
Spacegroup P6222 P6222  
Unit cell (a/b x c; Å) 63.74 x 66.33 63.64 x 66.49  
Resolution range (highest shell) 42.43-2.69 (2.82-2.69) 66.49-2.91 (3.08-2.91)  
Unique reflection 2489 (317) 1988 (298)  
Completeness (%) 100.0 (100.0) 99.9 (99.8)  
Redundancy 17.3 (15.1) 17.0 (18.0)  
<I/σ(I)> 39.7 (2.1) 22.7 (1.1)  
Rmerge 0.045 (1.336) 0.105 (3.006)  
Rpim 0.015 (0.470) 0.035 (0.988)  
Rmeas/rim 0.046 (1.387) 0.111 (3.166)  
Anomalous slope  1.195  
* This dataset could not be processed successfully; see Section 5.7.4. 
 
5.7. Structure solving and troubleshooting 
5.7.1. Apparent pathology 
While the collection of several high quality datasets at modest resolution was exciting, it 
was clear from the beginning that something was amiss with this crystal form. Given the unit cell 
dimensions and symmetry determined, presence of both strands of the DNAzme in the assymetric 
unit would take up > 100% of the volume of the unit cell. Typical values are ~50%, and often lower 
for nucleic acid structures. It was hypothesized that the space group might be apparently too high 
due to twinning, in which two lower symmetry unit cells co-crystalized in random distribution of 
orientations around one or more axes, to give data that appear a higher symmetry than they are. 
Luckily, statistical analyses have been developed that can detect twinning pathologies.66-69 This is 
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based on the fact that twining will result in overlapping of weak and strong reflections, resulting in 
a greater number of apparently strong reflections than expected. 66-69 Running these tests on these 
data, however, did not indicate that twinning is likely (Figure 5.4). 
 
Figure 5.4. Results of the L-test for twinning on the native dataset. 
An alternative crystal pathology that can result in higher apparent spacegroup is pseudo-
symmetry.70 If half of the DNAzyme structure as crystalized is similar in structure to the other half 
– after a rotation around an axis parallel to a crystallographic axis – then the point group of the 
asymmetric unit is higher than the true crystal symmetry and will cause the data to appear to be of 
higher symmetry than the true crystal symmetry. Alternatively, it might be possible that the crystal 
only contains one of the strands of DNA, homo-hybridized. In this case, it is would be not be 
possible that the crystal structure is of the real active form. In subsequent attempts to solve the 
structure of this crystal form, both possibilities we left open, and solutions were pursued in P6222 
and all possible lower symmetry spacegroups. 
5.7.2. Experimental phasing 
Given that no structures of DNAzymes are known, substantial effort was made to phase the 
structures using heavy-atom derivative difference phasing. A variety of experimental phasing 
techniques of increasing complexity and robustness have been established. Single-wavelength 
anomalous difference (SAD) phasing uses differences in intensities of opposed reflections in a single 
crystal due to X-ray absorption to locate heavy atom sites in structures. Multiple-wavelength 
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anomalous difference (MAD) phasing measures such differences at wavelengths below and above 
the absorption edge energy of the absorbing element to increase the S/N-ratio of the difference, but 
requires more robust crystals to prevent deterioration during several data collections. Single 
isomorphous replacement (SIR) phasing is carried out using the differences in intensities between 
two crystals, one containing a heavy atom and the other not. This technique offers similar signal 
improvements to MAD, but requires that the derivitization not cause major changes in the 
structure or unit cell parameters (>~1-2%). Multiple isomorphous replacement (MIR) is the most 
robust technique in terms of quality of the experimentally determined phases and was the first 
technique used to solve macromolecular crystal structures. However, as with SIR, it requires 
preparation of several derivatives with minimal perturbation of the structure, which can be 
challenging to achieve. Additionally, these techniques can be combined in a variety of ways to 
improve the quality of experimental phases. For instance, single isomorphous replacement with 
anomalous scattering (SIRAS) combines differences obtained between native and derivative crystals 
with anomalous differences within the derivative crystal to obtain more robust phases. 
A B 
 
Figure 5.5. SAD phasing solutions in P3 (A) and P6 (B) obtained from TaBr soaked data. 
The only crystal that gave measurable anomalous signal was the crystal soaked with TaBr. 
The crystal grown in Sr was subject to MAD data collection, but further crystal pathologies (see 
Section 5.7.4) prevented its use for MAD phasing. First attempts to phase the TaBr data using SAD 
phasing gave partial solutions in P6 and P3 space groups only. Analysis of the resulting electron 
density (Figure 5.5) showed distinct electron density spacing in certain regions consistent with B-
DNA base stacking distances. It was presumed that the overlapping and noisy density was a result 
of the fact that the spacegroup was wrong. It was suggested that a partial model built into the noisy 
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density could be a better model to use for molecular replacement to identify the correct spacegroup; 
however, even a reasonable partial model could not be built from these solutions. 
SIR and SIRAS phasing were also attempted with the TaBr data and the native data. Several 
partial solutions were obtained in a number of spacegroups (Figure 5.6). Again, several of these 
showed evidence of B-DNA base stacking. Attempts to build models into this density, however, also 
yielded no results.  
A 
 
B 
 
Figure 5.6.  Selected maps and map contours of solutions obtained from SIR/SIRAS phasing of TaBr and 
native datasets in P62 (A) and P32 (B) spacegroups. 
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5.7.3. Patterson analysis and molecular replacement 
A valuable analysis that gives insights into structural features of a crystal before its structure 
is solved is the Patterson map.71 This map is generated by mathematical convolution of the data 
with itself, and yields a representation of distance vectors between atoms.71 At high resolution (~1.2 
Å or better) and with fewer than ~1000 atoms, this map can be used to directly build the structure 
of a molecule from scratch.72,73 At low resolution, this map is used to identify heavy atom derivative 
sites in experimental phasing experiments, or to solve the phase problem by fitting the known 
structure of a similar molecule into the data of the structure being solved.73 Previously, it was shown 
that long stretches of B-DNA aligned along a cell axis give rise to distinctive peaks in the Patterson 
map (Figure 5.7A).74 Patterson analysis of the DNAzyme crystal data shows peaks consistent with 
this feature (Figure 5.7B). This observation reveals not only that some B-form DNA is present, but 
also the alignment of the helical axis within the crystal.  
A 
 
B 
 
Figure 5.7. (A) Patterson map cross-section of ideal pseudo-infinite B-DNA helix crystals. (B) Patterson map 
cross section of DNAzyme crystal data. Peaks consistent with B-DNA base stacking vectors are labeled with 
their vector lengths. 
The observation of B-DNA is not unexpected, as the construct specifically incorporated the 
Drew-Dickerson dodecamer (DDD) sequence, which is expected to exist as B-DNA. Recently, 
Roberston and Scott reported a novel, fragment-based approach to solving RNA crystal structures.75 
They hypothesized that while the 3D structures of new RNA sequences may not be known, the 
structures of many secondary structural features are well established, and that these fragments 
could be used as MR search models. Based on this approach, and the observation that B-DNA is 
present in the crystal, the structure of DDD was used for molecular replacement of our crystal 
structure in P6222 and lower spacegroups; however, this did not yield any results. Based on a 
hypothesis that part of the DDD may be disordered, a truncated octamer of the DDD structure was 
used as the search model. Again, no results were obtained. The molecular replacement protocol 
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was broken down into steps to attempt to troubleshoot the failure. The first step of MR is a rotation 
function (RF) search to orient the model within the crystal. Independent RF searches using the 
DDD octamer yielded successful results. Comparison of the Patterson map of the oriented model 
with that of the data confirmed that indeed that base-stacking features arise from B-DNA base 
stacking, and the hypothesis about the orientation of the helical axis. However subsequent 
translation function searches failed. Finally, the DDD was further broken down into three 
individual tetrameric B-DNA fragments. Use of these fragments in MR finally yielded solutions with 
statistics that were on the cusp that separates real solutions from false positives (Figure 5.8). 
Subsequent refinement of these solutions yielded statistics that were again on the cusp separating 
false positives and real solutions. However, such statistics were consistent with the results reported 
by Roberston and Scott, who successfully used this approach to phase a novel RNA structure. 75 
They reported that, while the statistics were not suggestive of a real solution, the resulting electron 
density maps clearly revealed real unmodeled density and areas that were mis-modeled. Visual 
inspection of the refinement results obtained here did not reveal clear unmodeled structural 
features. Attempts to auto-build DNA into the resulting electron density did not provide an 
improved structure from any of the solutions. 
P62 P32 
  
Figure 5.8. Best obtained solutions from MR using tetrameric fragments of DDD structure. 
5.7.4. Identification of multilattice pathology 
Upon attempted MAD data collection of the Sr-derivatized crystals, there arose some 
difficulties processing the data. The typical RAPD beamline pipeline failed to integrate and scale 
the dataset. Careful manual reanalysis showed apparently split spots along an off-diagonal vector 
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(Figure 5.9). In HKL2000, one set of spots could be indexed giving unit cell with dimensions 63 x 
63 x 65 Å. The remaining spots could then be indexed in 63 x 63 x 63 Å. Previously collected datasets 
were reanalyzed and also seemed to contain this pathology. It seems that there are a mixture of 
conformations, potentially due to a mixture of hybridization states between the substrate and 
enzyme strand. Due to the palindromic nature of the DDD sequence, it is possible for the 
hybridization to be not only E-S, but E-E or S-S as well, with overhangs on either end. Dissolving, 
quantitative labeling, and gel electrophoresis of a crystal showed that indeed, the strands seem 
present in unequal ratios in the crystal, suggesting at least two different hybridization modes. 
 
Figure 5.9.  Image showing double spots. 
 
Figure 5.10.  Gel of crystal showing unequal ratio of enzyme and substrate strands 
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5.8. Alternative approaches and future directions 
Given that this crystal form seems to have crystallographic pathology consisting of mis-
hybridization of the enzyme and substrate strands, it will be necessary to produce crystals of new 
constructs. Constructs will be screened with various mutations to the DDD to prevent mis-
hybridization, and extensions or truncations of the non-catalytic regions to optimize different 
packing interactions. Linked E-S constructs (called cis- constructs) will be attempted to encourage 
proper hybridization. In addition, co-crystallization with known DNA-co-crystallizable proteins 
will be attempted. Proteins such as polymerases bind DNA rigidly, and are known to co-crystallize 
with DNA. Engineering polymerase binding sequences into the non-catalytic portion of the DNA 
could allow the structure of the DNA to be determined. Co-crystallization with other prolifically 
crystallized proteins, such as MMLV-reverse transcriptase will also be pursued. Given the recent 
successful crystallization of a DNAzyme,46 we will also attempt to incorporate the non-catalytic 
regions of this DNAzyme into 8-17 DNAzyme, to enable crystal growth via the same intermolecular 
contacts. 
5.9. Materials and methods 
5.9.1. Materials 
All DNA sequences were obtained from IDT, unless otherwise noted. Chemicals were used 
as purchased from Sigma-Aldrich, unless noted otherwise.  
5.9.2. DNAzyme crystallization 
DNAzyme solution preparation and crystallization trials were carried out by members of 
DNA subgroup of the Lu lab. All crystals were obtained by hanging drop vapor diffusion at 4° C 
after about 6 months. Molecularly imprinted polymers (MIPs) were employed to help nucleate 
crystal growth.76 The crystallization conditions are given below. 
For room temperature diffraction and the native dataset, DNA solution consisting of 1.25 
mM DNA, 1.25 mM lead acetate, 6.25 mM sodium cacodylate pH 6.5, 2.5 mM magnesium chloride, 
and 2.5 mM H33342, was mixed with crystallization buffer consisting of 0.5 M ammonium sulfate, 
100 mM sodium cacodylate pH 5.5, 250 mM magnesium chloride, 1 mM lead acetate, and 5% 
isopropanol, and equilibrated by hanging drop vapor diffusion against the crystallization buffer. 
The drop was rehydrated with solution consisting of 1 M ammonium sulfate, 100 mM sodium 
cacodylate pH 5.5, 250 mM magnesium chloride, and 3% isopropanol, due to dehydration during 
harvesting. 
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For the native dataset, the crystal was soaked overnight in 1.1 M lithium sulfate, 100 mM 
sodium cacodylate pH 5.5, and 250 mM magnesium chloride. The crystal was subsequently 
transferred to solutions of the above containing increasing amounts of glycerol – 10% then 20%. 
The crystal was soaked in each of these for 15 min and cryocooled in liquid nitrogen after the 20% 
soak. 
For the TaBr derivatized dataset, the crystal was grown under the same conditions as above. 
The crystals was soaked in solution containing 1.1 M lithium sulfate, 100 mM MES pH 5.5, 250 mM 
magnesium chloride, and 10% w/v sodium gluconate for 20 minutes. The crystal was subsequently 
transferred to the same solution containing 1 mM TaBr cluster and soaked at 4° C overnight. The 
crystal obtained a dark green/blue color. This crystal was soaked in 1.1 M lithium sulfate, 100 mM 
MES pH 5.5, 250 mM magnesium chloride, and 30% w/v glycerol and harvested and cryocooled. 
Sr co-crystallization was carried out using crystallization buffer consisting of 0.5 M lithium 
chloride, 250 mM strontium chloride, 100 mM potassium cacodylate pH 5.5, and 25% ethylene 
glycol. This crystal was harvested and cryocooled directly due to the high ethylene glycol 
concentration. 
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APPENDIX A 
GENERAL METHODS 
A.1. Myoglobin expression and purification 
Proteins were expressed and purified as previously reported,1 with minor changes to 
improve yield and purity. Expression was carried out with E. coli BL-21 DE3 Star strain (Life 
Technologies); other strains produced inferior yield and purity. For purification from inclusion 
bodies, dialysis of protein after refolding was carried out against 10 mM tris sulfate pH 8.0. Dialysis 
was limited to two exchanges – first for 4 hours, second overnight. Protein was loaded onto the size 
exclusion column within 12 hours of completing dialysis. Protein batch activity was validated by 
oxygen reduction activity assays.1 
A.2. Oxygen activity assays 
The oxygen reduction rate assays were carried out as previously reported,1-3 using a Clark 
type oxygen electrode, ascorbate and TMPD as reductant and mediator, respectively, and ROS 
scavengers. 
A.2.1. Calculation of reactive oxygen species release rate 
The method of oxygen reduction data collection does not directly measure the production 
of water or reactive oxygen species. These are inferred indirectly from the apparent rate reduction 
imposed by ROS scavengers, catalase and superoxide dismutase, which disproportionate peroxide 
and superoxide, respectively, releasing ½ eq. of oxygen. In order to determine production of ROS, 
the rates were measured in the absence and presence of these scavengers.  
For every equivalent of oxygen that is converted to peroxide or superoxide, half of an 
equivalent will be converted back to oxygen by each of the scavengers. This means the rate of 
peroxide and superoxide production can be calculated as twice the difference in rate between the 
rates with and without scavengers. Likewise, the rate of oxygen conversion to water, is estimated 
as the total rate, less the calculated ROS production rate. Error propagation is used to calculate the 
errors. This calculation has been built into a standard Excel spreadsheet deposited with this thesis. 
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Figure A.1. Apparent oxygen consumption rates of G65Y-CuBMb in the presence and absence of ROS 
scavengers. The difference in rates is equal to half the rate of ROS production. 
𝑅𝑎𝑡𝑒𝑂2→𝑅𝑂𝑆 = 2 ∗ (𝑅𝑎𝑡𝑒 − 𝑅𝑎𝑡𝑒𝐶𝑎𝑡/𝑆𝑂𝐷) 
𝜎𝑂2→𝑅𝑂𝑆 = √4 ∗ 𝜎
2 − 4 ∗ 𝜎𝐶𝑎𝑡/𝑆𝑂𝐷
2  
𝑅𝑎𝑡𝑒𝑂2→𝐻2𝑂 = 2 ∗ 𝑅𝑎𝑡𝑒 − 𝑅𝑎𝑡𝑒𝐶𝑎𝑡/𝑆𝑂𝐷 
𝜎𝑂2→𝐻2𝑂 = √4 ∗ 𝜎
2 − 𝜎𝐶𝑎𝑡/𝑆𝑂𝐷
2  
A.3. Myoglobin crystallization condition optimization 
F33Y-CuBMb and FeBMb crystallization using PEG as the precipitant was optimized to 
produce larger, higher quality crystals in several steps. A screen was designed to vary multiple 
parameters simultaneously in four 24-well plates. This was done by dividing a 96 well box into 4 
quadrants and designing a 4 x 6 screen in each quadrant, such that one variable is changes vertically 
and another horizontally in each quadrant. The designed screen is shown below (Figure A.2). Each 
parameter was chosen to vary by ± 10% of its original value. The default conditions are 30% PEG 
10K, 100 mM sodium cacodylate pH 6.5, 200 mM sodium acetate. This custom screen was ordered 
from Emerald Bio (now Rigaku) 
These conditions were then used to screen crystallization of F33Y-CuBMb and FeBMb. An 
example is given below (Figure A.3). For both of these proteins, pH and [PEG] were found to be the 
most sensitive parameters. No trend was seen with salt concentration. Conditions around the best 
condition found from these screens were then further subject to fine optimization. In order to be 
able to vary pH efficiently, the pH of each buffer was not measured directly. Instead, 1M stock 
solutions were prepared that were assumed to consist entirely of acid (HA) or conjugate base (A-). 
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These were then mixed in appropriate ratios based on the Henderson-Hasselbalch equations. An 
example is given below in Table A.1 for MES buffer in the range of 5.8 to 6.8. The formula used is 
given to the right of the table. This method is based on the method used by Emerald Bio.  
→[NaOAc] 
[PEG] ↓ 
220.0 
mM 
206.7 
mM 
193.3 
mM 
180.0 
mM 
    →[protein] 
[PEG] ↓ 
27.0 %         27.0 % 
28.2 %         28.2 % 
29.4 %         29.4 % 
30.6 %         30.6 % 
31.8 %         31.8 % 
33.0 %         33.0 % 
27.0 %         5.85 
28.2 %         6.11 
29.4 %         6.37 
30.6 %         6.63 
31.8 %         6.89 
33.0 %         7.15 
→pH 
[PEG] ↓ 
7.15 6.82 6.28 5.85 220.0 
mM 
206.7 
mM 
193.3 
mM 
180.0 
mM 
pH ↓ 
→[NaOAc] 
Figure A.2. Crystal optimization screen conditions. 
 
 
Figure A.3. Results of FeBMb optimization screen.  
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Table A.1. Sample Excel spreadsheet for calculating mixing ratios for pH screening. 
pKa  6.1       
V[total] uL 100       
         
pH  5.8 6 6.2 6.4 6.6 6.8  
V[HA] uL 66.6 55.7 44.3 33.4 24.0 16.6 =$C$2-I6 
V[A-] uL 33.4 44.3 55.7 66.6 76.0 83.4 =$C$2*POWER(10,I$4-$C$1) 
/(1+POWER(10,I$4-$C$1)) 
HA/A-  1.9953 1.2589 0.794328 0.501187 0.316228 0.199526 =I5/I6 
A further optimization was to use MES buffer instead of cacodylate in the pH 6 range, for 
two reasons: (1) cacodylate is an arsenate toxin; (2) cacodylate causes high absorption upon X-ray 
irradiation, complicating correlated crystallography and spectroscopy. Similar optimization was 
carried out for I107E-CuBMb and G65Y-CuBMb. The final conditions for each of the proteins are 
given below (Table A.2). 
Table A.2.  Final crystal buffer conditions. Protein mixed 1:1 with buffer. 
Protein PEG 10K buffer salt [Protein] 
FeBMb 27% 100 mM NaMES pH 6.8 200 mM NaOAc 2 mM 
F33Y-CuBMb 30% 100 mM NaMES pH 6.7 200 mM NaOAc 1 mM 
I107E-CuBMb 30% 100 mM tris sulfate pH 8.6-8.7 200 mM NaOAc 1.5 mM 
G65Y-CuBMb 30% 100 mM tris sulfate pH 8.4 200 mM NaOAc 1.5 mM 
Finally, the crystallization was optimized by growing in large (100-200 μM) sitting drop 
conditions to grow crystals 200-500 μm in with and several mm in length. 
A.4. References 
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APPENDIX B 
APPARATUSES, METHODS, AND AUTOMATION FOR CRYSTALLOGRAPHY 
B.1. Inexpensive microscope display for facilitating anaerobic crystal manipulation 
Handling crystals in the glove bag is facilitated by use of a microscope. However, microscope 
use is hampered by the vinyl or plastic of the glove bag. A camera would alleviate these problems, 
but cameras for microscopes can be prohibitively expensive for some labs. Luckily, integrated 
consumer devices with cameras and displays are ubiquitous. I describe how a camera phone was 
attached to the microscope eyepiece in the glove bag, to act as a display. 
First, a rack consisting of metal bars and right angle connectors was fastened to the neck of 
the microscope. This was used as a bar on to which a clamp could be attached. This clamp is used 
to hold the camera in place near the eyepiece. The proper distance between the eyepiece and the 
camera optics was maintained by a rubber gasket, made from a septum by coring it. The camera 
was held in the correct position using a rubber band. 
 
Figure B.1. Photos of setup to use camera phone in place for use as a microscope display. 
B.2. Device and method for efficient and careful simultaneous soaking of many crystals 
Multicrystal data collection requires efficient preparation of many identical crystals. In case 
they need to be prepared before by multiple soaking steps, it is more efficient to soak them all 
simultaneously than individually. Here I describe a jury-rigged device and setup used to carefully 
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soak many identical crystals simultaneously (Figure B.2). This device has been successfully used 
numerous times for efficient anaerobic crystal soaking. 
 
 
Figure B.2.  Photos of device and setup used for simultaneous multicrystal, multistep soaking. 
The filter device was repurposed from a used, disposable PD-10 Minitrap G25 column (GE 
Life Sciences). The beads were disposed of and the tube was cut to about 0.5 cm above the bottom 
frit. A large septum was used as a support; the top of the septum was removed to make a hole 
straight through. A plastic tube of the appropriate diameter to fit snuggly in the outlet of the filter 
was inserted into the filter. A notch was cut so that the tube could pass under the device while it 
remains flat against the working surface. The tube was glued in place using super glue. The other 
end was attached to a syringe of appropriate volume by fitting the tube over a needle of appropriate 
diameter. This syringe could then be gently pumped with a syringe pump to withdraw solution 
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through the filter. Fresh solution is added through the top of the filter. A recommended withdrawal 
rate is 25 μL / min.  
B.3. MX+Spec collection at BioCARS 
The online microspectrophotometer setup at BioCARs1 was set up to collect spectroscopic 
(Spec) data interleaved with macromolecular X-ray diffraction (MX) data collection, to monitor 
crystal oxidation state. This is run through a script given below (Code B.2). The spectrophotometer 
is set to software trigger and started before data collection is initiate. The position at which to 
collect spectra and X-ray data are stored in a window on the computer and moves to these positions 
are initiated by the script as needed. The script saves 2 spectra per scan – the second one is more 
stabilized.  
Code B.1. Data collection steps for collecting data on 14-BM-C with interleaved spectroscopy. 
Procedure 
 
=== Out of hutch === 
 - Press 'Mount Sample' 
 - Close shutter and open door 
 - Bring in dewar, canes, cryotongs 
=== In hutch === 
 - ** Cover lens ** 
 - Remove sample 
 - Place next sample 
 - ** Uncover lens ** 
=== Out of hutch === 
 - Put cane in shipper 
 - Turn on light 
 - Center sample for X-ray 
 - ** Save X-ray position ** 
 - ** Set zero for microspec here ** 
 - Find best spec angle 
 - ** Save microspec position 
 - Turn of light 
 - Close lamp shutter - record dark 
 - Open shutter 
 - Set up time acqu. 
 - Set up screening script 
 - ** Confirm focus (beam size) ** 
=== In hutch === 
 - Put up 32 foils for ~95-99% atten. 
 - Search station 
=== Out of hutch === 
 - **! Confirm attenuation and saved positions !** 
 - Run screening script 
=== Index in MosFlm (!Remember to swap phi rotation!)  
         or integrate in HKL === 
=== Open hutch === 
 - Set desired attenuation for data collection 
 - ** Ensure total range and phi start ** 
 - Run collection script 
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Code B.2. Script to collect interleaved single crystal spectra during X-ray data collection. 
#!/usr/local/bin/python 
 
# Script to take spectra at a specific position. 
# -Drive to microspec position. 
# -Trigger microspec 
# -Drive back to previous position 
from epics import caget,caput,PV 
import Numeric 
import time,os,sys,urllib 
 
# DATA COLLECTION 
# 
# Data collection will start at starting_phi value. If phi_range_start != starting_phi, will 
continue collecting from phi_range_start to starting_phi 
# Ex. 
# phi_range_start = 95  
# starting_phi = 120  
# phi_range_end = 185 
# osc_width = 0.5 
# base_filename = Crystal_1 
#  
# Will result in files: 
# Crystal_1_A_001.img [phi 120.0->120.5] 
# Crystal_1_A_002.img [phi 120.5->121.0] 
# ... 
# Crystal_1_A_129.img [phi 184.0->184.5] 
# Crystal_1_A_130.img [phi 184.5->185.0] 
# Crystal_1_B_131.img [phi  95.0-> 95.5] 
# Crystal_1_B_132.img [phi  95.5-> 96.0] 
# ... 
# Crystal_1_B_180.img [phi 119.5->120.0] 
#  
 
phi_range_start = -118 # Start of full data collection range 
starting_phi = -54 # Phi-start of first frame 
phi_range_end = 2 # End of full data collection range 
osc_width = 0.5 
exposure_time = 3 
beamstop_distance = 40 
detector_distance = 170 
 
# MICROSPEC ACQ 
microspec_bins = [0,10,60,1000] # Frame ranges for microspec frequency determination 
microspec_frequency = [2,10,30] # Number of x-ray images between microspec spectrums 
 
# FILE OUTPUT 
directory = "/data/lu_1411/YL145-3/H1/" # Have to create manually 
base_filename = "YL145-3_H1" # This script will overwrite files!!!! 
restartNum = 1 # Flag (0|1) whether to restart numbering 
fileNum = 1 # First file number 
 
 
##################################### 
 
spec_num = 1 
 
def spectrum(): 
    caput("14BMC:DAC1_7.VAL",0) 
    # Drive to Save Sample position 1 
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    caput("14BMC:XYZ_phi_Select", 0) 
    time.sleep(0.1) 
    print "Moving to microspec position 1!!!" 
    while (caget("14BMC:phi.DMOV") == 0 or caget("14BMC:ESP300X.DMOV") == 0 or 
caget("14BMC:ESP300Y.DMOV") == 0 or caget("14BMC:ESP300Z.DMOV") == 0): 
        #print "Moving" 
        time.sleep(.5) 
    time.sleep(.5) 
 
    # Trigger DG535 
    print "Acquiring spectrum!!!" 
    caput("14BMC:DG535_1genSingleShotTrigBO", 1) 
    time.sleep(4) 
    caput("14BMC:DG535_1genSingleShotTrigBO", 1) 
##     for i in range(10): 
##         caput("14BMC:DG535_1genSingleShotTrigBO", 1) 
##         time.sleep(0.1) 
    time.sleep(5) 
    f.write("Collected Spec.\n") 
    f.flush() 
    caput("14BMC:DAC1_7.VAL",2) 
 
    # Move back to previous position 
    caput("14BMC:XYZ_phi_Select", 1) 
    print "Moving to x-ray position 2!!!" 
    time.sleep(0.1) 
    while (caget("14BMC:phi.DMOV") == 0 or caget("14BMC:ESP300X.DMOV") == 0 or 
caget("14BMC:ESP300Y.DMOV") == 0 or caget("14BMC:ESP300Z.DMOV") == 0): 
        #print "Moving" 
        time.sleep(.5) 
 
def xray_image(phi): 
    caput("14BMC:phi.VAL", phi, wait=True) 
    caput("14ADSC1:cam1:Acquire", 1) 
    caput("14BMC:xiaStart.PROC", 1) 
    time.sleep(0.1) 
    IC1=caget("14BMC:sclS1_cts1.D") 
    IC2=caget("14BMC:sclS1_cts2.A") 
    RC=caget("S:SRcurrentAI.VAL") 
    print "acq1" 
    while (caget("14ADSC1:cam1:DetectorState_RBV") != 0): 
        print ('.'), 
        IC2=caget("14BMC:sclS1_cts2.A") 
        time.sleep(0.1) 
    time.sleep(0.5) 
    print "acq2" 
    while (caget("14ADSC1:cam1:DetectorState_RBV") != 0): 
        print ('.'),        
        IC2=caget("14BMC:sclS1_cts2.A") 
        time.sleep(0.1) 
    time.sleep(0.5) 
    print "acq3" 
    while (caget("14ADSC1:cam1:DetectorState_RBV") != 0): 
        print ('.'),        
        time.sleep(0.1) 
    time.sleep(1) 
    f.write(str(phi)+" "+str(IC1)+" "+str(IC2)+" "+str(RC)+"\n") 
    val = pvFullFileName_RBV.get(as_string=True) 
    n=0 
Code B.2. (cont.) 
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    while (val == "" and n < 30): 
        time.sleep (1) 
        val = pvFullFileName_RBV.get(as_string=True) 
        n=n+1 
    print "File written (" + str(n) + "): " + val 
    f.write("File written: " + val + "\n") 
    f.flush() 
 
def xray_dark(): 
    #caput("14ADSC1:cam1:AutoSave", 0, wait=True) 
    res = caput("14ADSC1:cam1:FileName", "dark_file", wait=True) 
    if (res != 1): 
        sys.exit() 
    time.sleep(0.5) 
    res = caput("14ADSC1:cam1:AutoIncrement", 0, wait=True) 
    print "AutoIncrement: " + str(res) 
    if (res != 1): 
        sys.exit() 
    time.sleep(0.5) 
    res = caput("14ADSC1:cam1:Acquire", 1) 
    print "Acquire: " + str(res) 
    if (res != 1): 
        sys.exit() 
    time.sleep(0.1) 
    print "acq1" 
    while (caget("14ADSC1:cam1:DetectorState_RBV") != 0): 
        print ('.'), 
        time.sleep(0.5) 
    time.sleep(0.5) 
    print "acq2" 
    while (caget("14ADSC1:cam1:DetectorState_RBV") != 0): 
        print ('.'),        
        time.sleep(0.5) 
    time.sleep(0.5) 
    print "acq3" 
    while (caget("14ADSC1:cam1:DetectorState_RBV") != 0): 
        print ('.'),        
        time.sleep(0.5) 
    time.sleep(0.5) 
    #caput("14ADSC1:cam1:AutoSave", 1, wait=True) 
    time.sleep(0.5) 
    res = caput("14ADSC1:cam1:AutoIncrement", 1, wait=True) 
    print "AutoIncrement: " + str(res) 
    if (res != 1): 
        sys.exit() 
    time.sleep(0.5) 
    val = pvFullFileName_RBV.get(as_string=True) 
    n=0 
    while (val == "" and n < 30): 
        time.sleep (1) 
        val = pvFullFileName_RBV.get(as_string=True) 
    print "Wrote Dark (" + str(n) + "): " + val 
    f.write("Wrote Dark: " + val + "\n") 
    res = caput("14ADSC1:cam1:FileName", base_filename, wait=True) 
    if (res != 1): 
        sys.exit() 
    f.flush 
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print "Please confirm" 
print "Current IC1: "+str(caget("14BMC:sclS1_cts1.D")) 
print "Vertical JJ: "+str(caget("14BMC:jjvl.RBV"))+"\nHorizontal focal length 
"+str(caget("14BMA:SDD.RBV")) 
print str(exposure_time) + "s per " + str(osc_width) + " deg oscilation" 
answ = raw_input("=== (Y)es?: ") 
if answ != "Y": 
    sys.exit() 
print "Detector distance: "+str(detector_distance) 
print "Wedges: " +str(starting_phi) + "->"+str(phi_range_end)+", "+str(phi_range_start)+"-
>"+str(starting_phi) 
if ((starting_phi < phi_range_start) or (starting_phi > phi_range_end)): print "ERROR: 
starting_phi must be within phi range!"; sys.exit() 
print "Files will be saved as "+directory+base_filename+"_{A,B}_###.img" 
answ = raw_input("=== (Y)es?: ") 
if answ != "Y": 
    sys.exit() 
if restartNum == 1: 
    print "Numbering will be restarted at " + str(fileNum) 
else: 
    print "Numbering will not be restarted!!!" 
answ = raw_input("=== Continue? (Y): ") 
if answ != "Y": 
    sys.exit() 
print "Spectrum collection will be triggered after frame (spectrum file number):" 
temp_spec_num = spec_num 
bin = 0 
print str(int((phi_range_end-phi_range_start)/osc_width)) 
for i in range(int((phi_range_end-phi_range_start)/osc_width)): 
    if (i >= microspec_bins[bin+1]): 
 bin=bin+1 
    if ((i % microspec_frequency[bin]) == 0): 
 if (i == 0): print "0 (before exposure) (" + str(temp_spec_num) + ")" 
        else: print str(i) + "(" + str(temp_spec_num) + ")" 
        temp_spec_num = temp_spec_num + 2 
answ = raw_input("=== (Y)es?: ") 
if answ != "Y": 
    sys.exit() 
answ = raw_input("=== Did you start spectrum aqcuisition? (Y) ") 
if answ != "Y": 
    sys.exit() 
caput("14BMC:XYZ_phi1.DO2", 11111) 
print "X-ray:  " + str(caget("14BMC:XYZ_phi1.DO2")) + "  " + str(caget("14BMC:XYZ_phi1.DO3")) + 
"  " + str(caget("14BMC:XYZ_phi1.DO4")) + "  " + str(caget("14BMC:XYZ_phi1.DO5")) 
print "Spec:   " + str(caget("14BMC:XYZ_phi0.DO2")) + "  " + str(caget("14BMC:XYZ_phi0.DO3")) + 
"  " + str(caget("14BMC:XYZ_phi0.DO4")) + "  " + str(caget("14BMC:XYZ_phi0.DO5")) 
answ = raw_input("=== Are these positions correct? (Y) ") 
if answ != "Y": 
    sys.exit() 
 
f = open(directory+base_filename+".log",'a') 
time.ctime() 
f.write("Vertical beam: " + str(caget("14BMC:jjvl.RBV")) + "\nHorizontal focus at: " + 
str(caget("14BMA:SDD.RBV")) + "\n") 
f.write("X-ray Z = " + str(caget("14BMC:XYZ_phi1.DO5")) + "\n") 
f.write(str(osc_width) + " deg, " + str(exposure_time) + "s\n") 
f.write(time.strftime('%l:%M%p %Z on %b %d, %Y')+"\n") 
f.write("Angle IC1 IC2 RingCurrent\n") 
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caput("14ADSC1:cam1:FilePath", directory, wait=True) 
#caput("14ADSC1:cam1:FileName", base_filename, wait=True) 
#caput("14ADSC1:cam1:FileNumber", 1, wait=True) 
caput("14ADSC1:cam1:AcquireTime", exposure_time+0.8, wait=True) 
caput("14ADSC1:cam1:ADSCBeamX", 156.9, wait=True) 
caput("14ADSC1:cam1:ADSCBeamY", 157.0, wait=True) 
caput("14ADSC1:cam1:ADSCDistnce", detector_distance, wait=True) 
caput("14ADSC1:cam1:ADSCWavelen", 0.9787, wait=True) 
caput("14ADSC1:cam1:ADSCImWidth", osc_width, wait=True) 
caput("14ADSC1:cam1:ADSCPhi", osc_width, wait=True) 
caput("14BMC:xiaExposeTime", exposure_time, wait=True) 
caput("14BMC:oscWidth", osc_width, wait=True) 
caput("14BMC:bsz", beamstop_distance, wait=True) 
caput("14BMC:dz", detector_distance, wait=True) 
n=1 
 
pvFullFileName_RBV = PV("14ADSC1:cam1:FullFileName_RBV") 
#spectrum() 
xray_dark() 
if (restartNum == 1): 
    res = caput("14ADSC1:cam1:FileNumber", fileNum, wait=True) 
    if (res != 1): 
        exit 
    time.sleep(0.5) 
 
initial_range = range(int((phi_range_end-starting_phi)/osc_width)) 
ms_bin = 0 
 
caput("14ADSC1:cam1:FileName", base_filename + "_A", wait=True) 
for i in initial_range: 
    if (i >= microspec_bins[ms_bin+1]): 
 ms_bin=ms_bin+1 
    if ((i % microspec_frequency[ms_bin]) == 0): 
 urllib.urlretrieve("http://bmcvideo.cars.aps.anl.gov/axis-
cgi/jpg/image.cgi?camera=1&compression=0", 
directory+"Snap1_"+base_filename+str(caget("14ADSC1:cam1:FileNumber_RBV"))+".jpg") 
 urllib.urlretrieve("http://bmcvideo.cars.aps.anl.gov/axis-
cgi/jpg/image.cgi?camera=2&compression=0", 
directory+"Snap2_"+base_filename+str(caget("14ADSC1:cam1:FileNumber_RBV"))+".jpg") 
        spectrum() 
    caput("14ADSC1:cam1:ADSCPhi", (starting_phi+i*osc_width), wait=True) 
    print "X-ray image: " + str(caget("14ADSC1:cam1:FileNumber_RBV")) + " (phi " + 
str(starting_phi+i*osc_width) + " to " + str(starting_phi+(i+1)*osc_width) + ")" 
    xray_image(starting_phi+i*osc_width) 
 
caput("14ADSC1:cam1:FileName", base_filename + "_B", wait=True) 
if (len(initial_range) > 0): 
    modif = initial_range[-1] 
else: 
    modif = -1 
for i in range(int((starting_phi-phi_range_start)/osc_width)): 
    if ((i + 1 + modif) >= microspec_bins[ms_bin+1]): 
 ms_bin=ms_bin+1 
    if (((i + 1 + modif) % microspec_frequency[ms_bin]) == 0): 
 urllib.urlretrieve("http://bmcvideo.cars.aps.anl.gov/axis-
cgi/jpg/image.cgi?camera=1&compression=0", 
directory+"Snap1_"+base_filename+str(caget("14ADSC1:cam1:FileNumber_RBV"))+".jpg") 
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 urllib.urlretrieve("http://bmcvideo.cars.aps.anl.gov/axis-
cgi/jpg/image.cgi?camera=2&compression=0", 
directory+"Snap2_"+base_filename+str(caget("14ADSC1:cam1:FileNumber_RBV"))+".jpg") 
        spectrum() 
    caput("14ADSC1:cam1:ADSCPhi", (phi_range_start+i*osc_width), wait=True) 
    print "X-ray image: " + str(caget("14ADSC1:cam1:FileNumber_RBV")) + " (phi " + 
str(phi_range_start+i*osc_width) + " to " + str(phi_range_start+(i+1)*osc_width) + ")" 
    xray_image(phi_range_start+i*osc_width) 
         
spectrum() 
f.close() 
print "Data Collection Finished!!!" 
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APPENDIX C 
SOFTWARE FOR MULTI-CRYSTAL STRATEGY PREDICTION 
C.1. Background 
X-ray diffraction data collection requires exposure of crystals to intense X-ray beams for 
prolonged periods of time, and requiring 104-108 Gy of X-ray dose.1-3 At low doses within this range, 
redox active cofactors, such as metals and sulfur atoms, undergo redox state changes that may 
perturb the local structure.1-3 At high doses, the X-rays begin destroying macromolecular bonds, 
and deterioration of crystal diffraction becomes a concern.1-3 Due to this, multicrystal data-
collection is sometimes necessary to capture minimally perturbed states.4-7 In order to efficiently 
obtain the most complete data from the least amount of crystals, the relative orientations of the 
crystals with respect to the x-ray beam must be determined and the new crystal data collection 
must be optimized to collect the most unique data and least redundant data, and two tools have 
been made to help guide the data collection strategy, given information about past crystals. 
C.2. Current available tools 
The commonly used pipelines for strategy prediction for multiple crystals are in the Mosflm8 
and XDS9 pipelines. However, these pipelines are limited in their application. Mosflm can roughly 
predict what data was collected on previous crystals given their orientations, as determined by 
Mosflm previously, and predict where to best collect data on the current crystals. However, since it 
doesn’t take into account what data was actually collected and used from prior crystals, but only a 
predicition, it may miss holes. XDS in the other hand does read in actual collected data and predict 
data collection strategies based on the useable data of previous crystals. However, like Mosflm, XDS 
will only read in previously collected data that has been processed and merged using XDS. XDS 
itself has limited adoption among users due to being run from the command line. XDS is 
incorporated into specific beamline processing pipelines (BluIce at GM/CA, autoxds at SSRL, RAPD 
at NECAT) and its multicrystal strategy has been made accessible through these pipelines in some 
cases. However, these pipelines are not transferable between beamlines. Therefore, I sought to 
develop a multicrystal strategy program that would be more intuitive than XDS to save time during 
data collection, and compatible with multiple beamline and data-processing tools. 
C.3. Overview and usage 
My code is currently written to read in actually collected data processed from HKL2000,10 
an intuitive graphical data reduction software, and orientations from HKL2000 and Mosflm. It is 
straightforward to write a reader for other file types, and these will be added as time permits. The 
139 
 
interface is shown below (Figure C.1). Datasets from multiple crystals can be read-in, and then 
combined in a variety of combinations in which they might possibly be merged, by transferring to 
a dataset group in the list on the right. The data in the dataset group that has been collected can be 
plotted as a function of orientation of the currently selected OM crystal within the X-ray beam. 
 
Figure C.1. Overview of program interface. 
 
Figure C.2.  Screenshot of the plot of the above configuration. 
Once plotted, yellow spots indicate data that has been measured in the other crystals in the 
dataset group with “Data” selected. Red indicates uncollected data. The lower plot indicates the 
completeness at each angle of rotation of this crystal: the blue line is the total relative amount of 
unique reflections, yellow line is the amount that have been collected in other crystals, and pink is 
the fraction of total unique reflections collected. 
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A wedge of data can be marked by dragging horizontally to visualize what reflections will 
be collected in a sweep of those angles (Figure C.3). 
 
Figure C.3. Plot with scan from Phi 118-130° marked for collection. 
When a dataset with collected data is plotted, the data collected from that dataset show up 
as black (for the phi range that was actually collected) and blue (for symmetry related reflection). 
 
Figure C.4. Plot in orientation of a collected dataset. 
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Using this tool, one can continue to visually add data as its collected, remove data that may 
be bad, and plan the data collection on the next crystal, with their choice of data processing 
software. 
C.4. Future directions 
This code will continue to be developed in collaboration. Bugs need to be worked out and 
new file type support needs to be added. Then the program will be further extended to help analyze 
datasets and determine which ones are compatible with each other and mergable. The ability to 
view correlated spectroscopic data is planned. An eventual portable suite is planned that can be 
used for multicrystal dataset management and planning on any beamline. The code is written in 
Java, and so is portable to any common OS. 
C.5. Code 
Once completed, the code will be made available through SourceForge. 
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